# EDGAR Filing Document

**Accession Number:** 0000874396
**File Stem:** 0000874396-25-000022
**Filing Date:** 2025-11
**Character Count:** 187011
**Document Hash:** d4df185122cc3a4143dd5344e3a9b7b7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000874396-25-000022.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0000874396-25-000022

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LIFETIME BRANDS, INC
- **CENTRAL INDEX KEY:** 0000874396
- **STANDARD INDUSTRIAL CLASSIFICATION:** CUTLERY, HANDTOOLS & GENERAL HARDWARE [3420]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 112682486
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19254
- **FILM NUMBER:** 251458511

**BUSINESS ADDRESS:**
- **STREET 1:** 1000 STEWART AVENUE
- **CITY:** GARDEN CITY
- **STATE:** NY
- **ZIP:** 11530
- **BUSINESS PHONE:** 5166836000

**MAIL ADDRESS:**
- **STREET 1:** 1000 STEWART AVENUE
- **STREET 2:** 1000 STEWART AVENUE
- **CITY:** GARDEN CITY
- **STATE:** NY
- **ZIP:** 11530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIFETIME HOAN CORP
- **DATE OF NAME CHANGE:** 19930328

?xml version='1.0' encoding='ASCII'? lcut-20250930

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**__________________________**

**FORM 10-Q**

**__________________________**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended: September 30, 2025**

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission File Number: 0-19254**

**__________________________**

**LIFETIME BRANDS, INC.**

**(Exact name of registrant as specified in its charter)**

**__________________________**

---

| | |
|:---|:---|
| **Delaware** | **11-2682486** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

**1000 Stewart Avenue, Garden City, New York 11530**

**(Address of principal executive offices) (Zip Code)**

**(516) 683-6000**

**(Registrant's telephone number, including area code)**

**__________________________**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange<br>on which registered** |
| **Common Stock, $.01 par value** | **LCUT** | **The Nasdaq Global Select Market** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

The number of shares of the registrant's common stock outstanding as of October 31, 2025 was 22,655,990.

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**LIFETIME BRANDS, INC.**

**FORM 10-Q**

**FOR THE QUARTER ENDED SEPTEMBER 30, 2025**

**INDEX**

---

| | | |
|:---|:---|:---|
| | | **Page No.** |
| **Part I.** | **<u>[Financial Information](#i77ef68f3fc204c9ba7520d18e4264663_10)</u>** | |
| Item 1. | <u>[Financial Statements](#i77ef68f3fc204c9ba7520d18e4264663_13)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets –](#i77ef68f3fc204c9ba7520d18e4264663_16)September 30, 2025[(unaudited) and](#i77ef68f3fc204c9ba7520d18e4264663_16)December 31, 2024</u> | <u>[2](#i77ef68f3fc204c9ba7520d18e4264663_16)</u> |
|  | <u>[Condensed Consolidated Statements of Operations (unaudited) –](#i77ef68f3fc204c9ba7520d18e4264663_19)Three and Nine Months EndedSeptember 30, 2025[and](#i77ef68f3fc204c9ba7520d18e4264663_19)2024</u> | <u>[3](#i77ef68f3fc204c9ba7520d18e4264663_19)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive](#i77ef68f3fc204c9ba7520d18e4264663_22)(Loss) Income[(unaudited) –](#i77ef68f3fc204c9ba7520d18e4264663_22) Three and Nine Months Ended September 30, 2025 and 2024</u> | <u>[4](#i77ef68f3fc204c9ba7520d18e4264663_22)</u> |
|  | <u>[Condensed Consolidated Statements of Stockholders' Equity (unaudited) –](#i77ef68f3fc204c9ba7520d18e4264663_25)Three and Nine Months Ended September 30, 2025 and 2024</u> | <u>[5](#i77ef68f3fc204c9ba7520d18e4264663_25)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows (unaudited) –](#i77ef68f3fc204c9ba7520d18e4264663_28) Nine Months Ended September 30, 2025 and 2024</u> | <u>[7](#i77ef68f3fc204c9ba7520d18e4264663_28)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#i77ef68f3fc204c9ba7520d18e4264663_31)</u> | <u>[8](#i77ef68f3fc204c9ba7520d18e4264663_31)</u> |
| Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i77ef68f3fc204c9ba7520d18e4264663_76)</u> | <u>[30](#i77ef68f3fc204c9ba7520d18e4264663_76)</u> |
| Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i77ef68f3fc204c9ba7520d18e4264663_109)</u> | <u>[44](#i77ef68f3fc204c9ba7520d18e4264663_109)</u> |
| Item 4. | <u>[Controls and Procedures](#i77ef68f3fc204c9ba7520d18e4264663_112)</u> | <u>[44](#i77ef68f3fc204c9ba7520d18e4264663_112)</u> |
| **Part II.** | **<u>[Other Information](#i77ef68f3fc204c9ba7520d18e4264663_115)</u>** |  |
| Item 1. | <u>[Legal Proceedings](#i77ef68f3fc204c9ba7520d18e4264663_118)</u> | <u>[44](#i77ef68f3fc204c9ba7520d18e4264663_115)</u> |
| Item 1A. | <u>[Risk Factors](#i77ef68f3fc204c9ba7520d18e4264663_121)</u> | <u>[44](#i77ef68f3fc204c9ba7520d18e4264663_121)</u> |
| Item 5. | <u>[Other Information](#i77ef68f3fc204c9ba7520d18e4264663_127)</u> | <u>[45](#i77ef68f3fc204c9ba7520d18e4264663_127)</u> |
| Item 6. | <u>[Exhibits](#i77ef68f3fc204c9ba7520d18e4264663_130)</u> | <u>[46](#i77ef68f3fc204c9ba7520d18e4264663_130)</u> |
| <u>[Signatures](#i77ef68f3fc204c9ba7520d18e4264663_133)</u> | <u>[Signatures](#i77ef68f3fc204c9ba7520d18e4264663_133)</u> | <u>[47](#i77ef68f3fc204c9ba7520d18e4264663_133)</u> |

---

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**LIFETIME BRANDS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(in thousands, except share data)

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | (unaudited) | |
| **ASSETS** |  |  |
| CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $12125 | $2929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, less allowances of $15,636 at September 30, 2025 and $14,093 at December 31, 2024 | 127827 | 156743 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | 221185 | 202408 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 11616 | 11488 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable | 2215 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TOTAL CURRENT ASSETS | 374968 | 373568 |
| PROPERTY AND EQUIPMENT, net | 15270 | 15049 |
| OPERATING LEASE RIGHT-OF-USE ASSETS | 51777 | 59571 |
| INTANGIBLE ASSETS, net | 137271 | 183527 |
| OTHER ASSETS | 1838 | 2595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $581124 | $634310 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current maturity of term loan | $4987 | $4891 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 49786 | 60029 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 67495 | 70848 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable |  | 830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 16277 | 15145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TOTAL CURRENT LIABILITIES | 138545 | 151743 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OTHER LONG-TERM LIABILITIES | 15720 | 15955 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES PAYABLE, LONG-TERM | 706 | 706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OPERATING LEASE LIABILITIES | 46154 | 56740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DEFERRED INCOME TAXES | 5747 | 5601 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REVOLVING CREDIT FACILITY | 62411 | 42693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TERM LOAN | 127196 | 130949 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;STOCKHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $1.00 par value, shares authorized: 100 shares of Series A and 2,000,000 shares of Series B; none issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, shares authorized: 50,000,000 at September 30, 2025 and December 31, 2024; shares issued and outstanding: 22,657,435 at September 30, 2025 and 22,155,735 at December 31, 2024 | 227 | 222 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | 283248 | 280566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (80610) | (32550) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (18220) | (18315) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TOTAL STOCKHOLDERS' EQUITY | 184645 | 229923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $581124 | $634310 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**LIFETIME BRANDS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

(in thousands, except per share data)

(unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net sales | $171912 | $183837 | $443859 | $467745 |
| Cost of sales | 111488 | 116420 | 281959 | 288231 |
| Gross margin | 60424 | 67417 | 161900 | 179514 |
| Distribution expenses | 17939 | 20034 | 53323 | 51267 |
| Selling, general and administrative expenses | 35488 | 38770 | 104451 | 116637 |
| Goodwill impairment |  |  | 33237 |  |
| Restructuring expenses | 304 |  | 304 |  |
| Income (loss) from operations | 6693 | 8613 | (29415) | 11610 |
| Interest expense | (5013) | (5834) | (14982) | (16605) |
| Mark to market loss on interest rate derivatives | (8) | (928) | (755) | (1184) |
| Loss on equity securities |  |  |  | (14152) |
| Income (loss) before income taxes and equity in losses | 1672 | 1851 | (45152) | (20331) |
| Income tax (provision) benefit | (2861) | (1507) | 63 | (1660) |
| Equity in losses, net of taxes |  |  |  | (2092) |
| **NET (LOSS) INCOME** | $(1189) | $344 | $(45089) | $(24083) |
| **BASIC (LOSS) INCOME PER COMMON SHARE** | $(0.05) | $0.02 | $(2.08) | $(1.12) |
| **DILUTED (LOSS) INCOME PER COMMON SHARE** | $(0.05) | $0.02 | $(2.08) | $(1.12) |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**LIFETIME BRANDS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME**

(in thousands)

(unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net (loss) income | $(1189) | $344 | $(45089) | $(24083) |
| Other comprehensive income, net of taxes: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in translation adjustment | (81) | 872 | 531 | 15117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in cash flow hedges | 141 | (203) | (449) | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of retirement benefit obligations | 5 | 13 | 13 | 38 |
| Other comprehensive income, net of taxes | 65 | 682 | 95 | 15175 |
| Comprehensive (loss) income | $(1124) | $1026 | $(44994) | $(8908) |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**LIFETIME BRANDS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

(in thousands)

(unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common stock** | **Common stock** | **Paid-in<br>capital** | **Accumulated deficit** | **Accumulated other**<br>**comprehensive**<br> **loss** | **Total** |
| | **Shares** | **Amount** | **Paid-in<br>capital** | **Accumulated deficit** | **Accumulated other**<br>**comprehensive**<br> **loss** | **Total** |
| **BALANCE AT DECEMBER 31, 2024** | 22156 | $222 | $280566 | $(32550) | $(18315) | $229923 |
| Net loss |  |  |  | (4201) |  | (4201) |
| Other comprehensive income, net of taxes |  |  |  |  | 292 | 292 |
| Net issuance of restricted shares granted to employees | 338 | 3 | (3) |  |  |  |
| Stock compensation expense |  |  | 1063 |  |  | 1063 |
| Shares effectively repurchased for required employee withholding taxes | (80) | (1) | (415) |  |  | (416) |
| Dividends <sup>(1)</sup> |  |  |  | (985) |  | (985) |
| **BALANCE AT MARCH 31, 2025** | 22414 | $224 | $281211 | $(37736) | $(18023) | $225676 |
| Net loss |  |  |  | (39699) |  | (39699) |
| Other comprehensive loss, net of taxes |  |  |  |  | (262) | (262) |
| Net issuance of restricted shares granted to employees and directors | 243 | 3 | (3) |  |  |  |
| Stock compensation expense |  |  | 1044 |  |  | 1044 |
| Dividends <sup>(1)</sup> |  |  |  | (991) |  | (991) |
| **BALANCE AT JUNE 30, 2025** | 22657 | $227 | $282252 | $(78426) | $(18285) | $185768 |
| Net loss |  |  |  | (1189) |  | (1189) |
| Other comprehensive income, net of taxes |  |  |  |  | 65 | 65 |
| Stock compensation expense |  |  | 996 |  |  | 996 |
| Dividends <sup>(1)</sup> |  |  |  | (995) |  | (995) |
| **BALANCE AT SEPTEMBER 30, 2025** | 22657 | $227 | $283248 | $(80610) | $(18220) | $184645 |

---

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common stock** | **Common stock** | **Paid-in<br>capital** | **Accumulated deficit** | **Accumulated other<br>comprehensive<br> loss** | **Total** |
| | **Shares** | **Amount** | **Paid-in<br>capital** | **Accumulated deficit** | **Accumulated other<br>comprehensive<br> loss** | **Total** |
| **BALANCE AT DECEMBER 31, 2023** | 21813 | $218 | $277728 | $(13568) | $(33499) | $230879 |
| Net loss |  |  |  | (6260) |  | (6260) |
| Other comprehensive income, net of taxes |  |  |  |  | 254 | 254 |
| Performance shares issued to employees | 152 | 2 | (2) |  |  |  |
| Net issuance of restricted shares granted to employees | 213 | 2 | (2) |  |  |  |
| Stock compensation expense |  |  | 799 |  |  | 799 |
| Shares effectively repurchased for required employee withholding taxes | (105) | (1) | (1027) |  |  | (1028) |
| Dividends <sup>(1)</sup> |  |  |  | (943) |  | (943) |
| **BALANCE AT MARCH 31, 2024** | 22073 | $221 | $277496 | $(20771) | $(33245) | $223701 |
| Net loss |  |  |  | (18167) |  | (18167) |
| Other comprehensive income, net of taxes |  |  |  |  | 14239 | 14239 |
| Net issuance of restricted shares granted to employees and directors | 92 | 1 | (1) |  |  |  |
| Stock compensation expense |  |  | 1044 |  |  | 1044 |
| Shares effectively repurchased for required employee withholding taxes | (7) |  | (55) |  |  | (55) |
| Dividends <sup>(1)</sup> |  |  |  | (957) |  | (957) |
| **BALANCE AT JUNE 30, 2024** | 22158 | $222 | $278484 | $(39895) | $(19006) | $219805 |
| Net income  |  |  |  | 344 |  | 344 |
| Other comprehensive income, net of taxes |  |  |  |  | 682 | 682 |
| Net issuance of restricted shares granted to employees | (1) |  |  |  |  |  |
| Stock compensation expense |  |  | 1046 |  |  | 1046 |
| Dividends <sup>(1)</sup> |  |  |  | (959) |  | (959) |
| **BALANCE AT SEPTEMBER 30, 2024** | 22157 | $222 | $279530 | $(40510) | $(18324) | $220918 |

---

<sup>(1)</sup> Cash dividends declared per share of common stock were $0.1275 and $0.1275 in the nine months ended September 30, 2025 and 2024, respectively.

See accompanying notes to unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>

**LIFETIME BRANDS, INC.** 

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(in thousands) (unaudited)

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(45089) | $(24083) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16533 | 16241 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment | 33237 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of financing costs | 2077 | 2195 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on disposition of fixed assets | (94) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark to market loss on interest rate derivatives | 755 | 1184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases, net | (1734) | (1476) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (recovery) for doubtful accounts | 1129 | (241) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes |  | 144 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 3100 | 2886 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in losses, net of taxes |  | 2092 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on equity securities |  | 14152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 29010 | 13859 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | (15912) | (44821) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses, other current assets and other assets | (224) | 2929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued expenses and other liabilities | (15843) | 16759 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable | (2215) | (2894) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | (860) | (663) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES** | 3870 | (1737) |
| **INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (3221) | (1604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from sale of property  | 94 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**NET CASH USED IN INVESTING ACTIVITIES** | (3127) | (1604) |
| **FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility | 236941 | 180725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of revolving credit facility | (219726) | (177984) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of term loan | (5625) | (5625) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for finance lease obligations | (33) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of tax withholding for stock based compensation | (416) | (1083) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends paid | (2858) | (2893) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES** | 8283 | (6882) |
| Effect of foreign exchange on cash | 170 | 18 |
| **INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS** | 9196 | (10205) |
| Cash and cash equivalents at beginning of period | 2929 | 16189 |
| **CASH AND CASH EQUIVALENTS AT END OF PERIOD** | $12125 | $5984 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 1 — BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES**

**Organization and business**

Lifetime Brands, Inc. ("the Company") designs, sources and sells branded kitchenware, tableware and other products used in the home and markets its products under a number of widely-recognized brand names and trademarks, which are either owned or licensed by the Company or through retailers' private labels and their licensed brands. The Company's products, which are targeted primarily towards consumers purchasing moderately priced kitchenware, tableware and housewares, are sold through nearly every major level of trade. The Company generally markets several lines within each of its product categories under more than one brand. The Company sells its products directly to retailers (who may resell the Company's products through their websites) and, to a lesser extent, to distributors. The Company also sells a selection of its products directly to consumers through its own websites.

**Basis of presentation**

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and with the instructions to Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist of normal recurring accruals and non-recurring adjustments, considered necessary for a fair presentation have been included. Certain immaterial amounts from the prior year have been reclassified to conform to the current year presentation.

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Operating results for the three and nine months ended September 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025.

The Company's business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2024 and 2023, net sales for the third and fourth quarters accounted for 58% and 57% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period.

The Company's current estimates contemplate current and expected future conditions, as applicable; however it is reasonably possible that actual conditions could differ from expectations, which could materially affect the Company's results of operations and financial position.

**Revenue recognition**

The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are primarily recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products.

The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and an estimate for products expected to be returned are reflected as reductions of revenue at the time of sale. See NOTE 2 —REVENUE to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

**Cost of sales**

Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, handling costs, duties and tariffs, royalties, and other product procurement related charges.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**Distribution expenses**

Distribution expenses consist primarily of warehousing expenses and freight-out expenses.

**Accounts receivable**

The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated credit losses that could result from the inability of its customers to make required payments, taking into consideration customer credit history and financial condition, industry and market segment information, credit reports, and expectations of current and future economic conditions. A considerable amount of judgment is required to assess the ultimate realization of these receivables including assessing the initial and on-going creditworthiness of the Company's customers.

The Company also maintains an allowance for anticipated customer deductions. Contractual deductions for incentives and promotions granted to customers such as cooperative advertising, are recorded as a reduction to accounts receivable at the time of sale. These deductions are primarily fixed amounts; however, in certain cases, these deductions are not fixed and, therefore, the allowance is estimated based on currently available information and historical trends of deductions.

**Receivable purchase agreement**

The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association ("HSBC") as Purchaser (the "Receivables Purchase Agreement"). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company's unaudited condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company's unaudited condensed consolidated statements of operations. The Company did not sell receivables to HSBC during the three and nine months ended September 30, 2025 and September 30, 2024.

At September 30, 2025, $13.6 million of accounts receivables were available for sale to HSBC, net of applicable charges.

**Inventory**

Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company's manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product-by-product basis based on the current selling environment. If the estimated selling price is lower than the inventory's cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.

The components of inventory were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** |
| Finished goods | $212114 | $192480 |
| Work in process | 41 | 62 |
| Raw materials | 9030 | 9866 |
| Total | $221185 | $202408 |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**Fair value of financial instruments**

The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its ABL Agreement and Term Loan (each as defined in NOTE 6 — DEBT to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q) approximate fair value since such borrowings bear interest at variable market rates.

**Derivatives**

The Company accounts for derivative instruments in accordance with Accounting Standard Codification ("ASC") Topic 815, *Derivatives and Hedging (*"ASC 815"*)*. ASC 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes are included in accumulated other comprehensive loss and are subsequently recognized in the Company's unaudited condensed consolidated statements of operations in the same period that the hedged items are recognized in earnings. Changes in fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company's unaudited condensed consolidated statements of operations.

**Goodwill, intangible assets and long-lived assets**

Goodwill is not amortized but, instead, subject to an annual impairment assessment on October 1 or more frequently if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable.

As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative goodwill impairment testing described in the Financial Accounting Standards Board's ("FASB") ASC Topic 350, Intangibles – Goodwill and Other. If, after assessing qualitative factors, the Company determines that it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, then no further testing is performed for that reporting unit. However, if based on the Company's qualitative assessment it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. Impairment testing is based upon the best information available, including estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. The Company performed its annual impairment assessment of its U.S. reporting unit as of October 1, 2024 by comparing the fair value of the reporting unit with its carrying value. The Company performed the analysis using a discounted cash flow and market multiple method. As of October 1, 2024, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 5%.

In the second quarter of 2025, the Company observed a sustained decline in the market valuation of the Company's common stock. Additionally, the Company's near term forecasts for the U.S. reporting unit were revised downward due to changes in retailer and consumer buying patterns, which were impacted by the recent changes in the U.S. tariff policies. Based on these factors the Company concluded that impairment indicators for the U.S. reporting unit were present as of June 30, 2025.

The Company performed an interim impairment test of the goodwill in the U.S. reporting unit as of June 30, 2025 by comparing its fair value with its carrying value. The analysis was performed by using a discounted cash flow and market multiple method. Accordingly, this fair value measurement is classified as Level 3 since it is based primarily on unobservable inputs. Based upon the analysis performed, the Company's U.S. reporting unit goodwill was fully impaired and a $33.2 million non-cash goodwill impairment charge was recognized. The goodwill impairment charge was the result of the decline in the Company's near term forecasts that were revised downward due to the changes in retailer and consumer buying patterns and an increase to the company-specific risk premium, which is an input to the cost of capital assumption, to address the potential risks in the long-term forecast which remain uncertain at this time. As of September 30, 2025, the Company's goodwill balance was zero.

The significant assumptions used under the income approach, or discounted cash flow method, are projected net sales, projected earnings before interest, tax, depreciation and amortization ("EBITDA"), and the cost of capital. Projected net sales and projected EBITDA were determined to be significant assumptions because they are the primary drivers of the projected cash flows in the discounted cash flow fair value model. Cost of capital was also determined to be a significant assumption as it is the discount rate used to calculate the current fair value of those projected cash flows. The calculation of cost of capital includes

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

a number of subjective inputs, including a company-specific risk premium to capture the perceived risks associated with the reporting unit's projected cash flows used in the discounted cash flow method.

Determining fair value using a market approach considers multiples of financial metrics based on both acquisitions and trading multiples of a selected peer group of companies. From the comparable companies, a representative market multiple is determined which is applied to financial metrics to estimate the fair value of a reporting unit.

Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset is not recoverable, the impairment to be recognized is measured by the amount by which the carrying amount of each long-lived asset exceeds the fair value of the asset.

See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

**Leases**

The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use ("ROU") assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other long-term liabilities. The Company's finance leases are not material to the Company's condensed consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Periods to extend the lease are included in the lease term when the Company is reasonably certain that the extension option would be exercised, and the associated lease payments for such periods are reflected in the ROU asset and lease liability. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet.

The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized.

**Restructuring Expenses**

Restructuring costs are recognized at fair value when the related liability is incurred. For severance and other employee-related costs, a liability is generally incurred on the date the restructuring plan is communicated to affected employees.

For the three and nine months ended September 30, 2025, the Company's International segment incurred $0.3 million of restructuring expenses related to severance associated with the reorganization of the International segment's workforce. The reorganization is in connection with Project Concord and primarily affects the structure of the International segment's merchandising and sales workforce.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**New accounting pronouncements**

Updates not listed below were assessed and either determined to not be applicable or are expected to have a minimal effect on the Company's financial position, results of operations, and disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures: This guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. The new guidance is effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Retrospective application is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The guidance requires additional disclosure in the notes to the financial statements for specified information about certain costs and expenses. The new guidance is effective for public business entities for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

**NOTE 2 —REVENUE**

The Company sells products wholesale, to retailers and distributors, and retail, directly to consumers. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company's principal terms of sale are Free On Board ("FOB") Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. Shipping and handling fees that are billed to customers in sales transactions are included in net sales and amounted to $1.1 million and $2.5 million, respectively, for the three and nine months ended September 30, 2025 and $0.9 million and $2.2 million, respectively, for the three and nine months ended September 30, 2024. Net sales exclude taxes that are collected from customers and remitted to the taxing authorities.

The Company offers various sales incentives and promotional programs to its wholesale customers from time to time in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These sales incentives and promotions represent variable consideration and are reflected as reductions in net sales in the Company's unaudited condensed consolidated statements of operations. While many of the sales incentives and promotions are contractually agreed upon with the Company's customers, certain of the sales incentives and promotions are non-contractual and require the Company to estimate the amount of variable consideration based on historical experience and other known factors or as the most likely amount in a range of possible outcomes. On a quarterly basis, variable consideration is assessed on a portfolio approach in estimating the extent to which the components of variable consideration are constrained. Payment terms vary by customer, but generally range from 30 to 90 days or at the point of sale for the Company's retail direct sales.

The Company incurs certain direct incremental costs to obtain contracts with customers, such as sales-related commissions, where the recognition period for the related revenue is less than one year. These costs are expensed as incurred and recorded within selling, general and administrative expenses in the unaudited condensed consolidated statements of operations. Incidental items that are immaterial in the context of the contract are expensed as incurred.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

The following tables present the Company's net sales disaggregated by segment, product category and geographic region for the three and nine months ended September 30, 2025 and 2024 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **U.S. segment** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kitchenware | $98558 | $97343 | $260628 | $261660 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tableware | 31634 | 40917 | 80534 | 93017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home Solutions | 27929 | 31962 | 64784 | 76528 |
| Total U.S. segment | 158121 | 170222 | 405946 | 431205 |
| **International segment** | 13791 | 13615 | 37913 | 36540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $171912 | $183837 | $443859 | $467745 |
| United States | $151041 | $159759 | $390292 | $409588 |
| United Kingdom | 8763 | 8909 | 22950 | 23525 |
| Rest of World | 12108 | 15169 | 30617 | 34632 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $171912 | $183837 | $443859 | $467745 |

---

**NOTE 3 — LEASES**

The Company has operating leases for corporate offices, distribution facilities, a manufacturing plant, and certain vehicles.

The components of lease expense for the three and nine months ended September 30, 2025 and 2024 were as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** <br>**September 30,** | **Three Months Ended** <br>**September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Operating lease expenses<sup>(1)</sup>: |  |  |  |  |
| Fixed lease expense | $4326 | $4276 | $12902 | $12804 |
| Variable lease expense | 1600 | 1628 | 5165 | 4646 |
| **Total** | $5926 | $5904 | $18067 | $17450 |

---

<sup>(1)</sup> Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations.

Supplemental cash flow information for lease related liabilities and assets for the nine months ended September 30, 2025 and 2024 were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Cash paid for amounts included in the measurement of lease liabilities:** |  |  |
| Operating cash flows for operating leases | $14636 | $14280 |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Right-of-use assets obtained in exchange for lease obligations:** |  |  |
| Operating leases | $754 | $479 |

---

The aggregate future lease payments for operating leases as of September 30, 2025 were as follows (in thousands):

---

| | |
|:---|:---|
| | **Operating** |
| 2025 (excluding the nine months ended September 30, 2025) | $4900 |
| 2026 | 19315 |
| 2027 | 15080 |
| 2028 | 13068 |
| 2029 | 6829 |
| 2030 | 5007 |
| Thereafter | 9234 |
| Total lease payments | 73433 |
| Less: Interest | (11002) |
| Present value of lease payments | $62431 |

---

Average lease terms and discount rates were as follows:

---

| | |
|:---|:---|
| | **September 30, 2025** |
| **Operating leases:** | |
| Weighted-average remaining lease term (years) | 4.8 |
| Weighted-average discount rate | 6.6% |

---

On January 23, 2025, the Company entered into a lease agreement for a new distribution center in Hagerstown, Maryland

("Hagerstown Facility"). The term of the lease is 180 months following the rent commencement date, which will occur in the first quarter of 2026. Base rent for the first year of the lease is $7.3 million, escalating by 3% annually. A portion of the base rent will be abated for the first 36 months at the annual prevailing rate for a total rent abatement of $7.2 million. The lease agreement also includes a total tenant improvement allowance of $5.1 million.

**NOTE 4 —INVESTMENT**

As of September 30, 2025, the Company has a 24.7% interest in Grupo Vasconia S.A.B. ("Vasconia"), an integrated manufacturer of aluminum products and a housewares company in Mexico. Shares of Vasconia's capital stock are traded on the Bolsa Mexicana de Valores, the Mexican Stock Exchange. The Quotation Key is VASCONI. During the second quarter of 2024, Vasconia's shareholders approved a resolution to a reorganization process in terms of the Law of Commercial Bankruptcy in Mexico and subsequently a bankruptcy suit was filed against Vasconia by one of its largest suppliers. The Company concluded that the events constituted a loss of significant influence and resulted in the discontinuation of the equity method of accounting. The Company accounts for its Vasconia investment at fair value in accordance with Accounting Standards Codification ("ASC") *Topic 321: Investments — Equity Securities*, with any changes in fair value recorded within income (loss) on equity securities on the consolidated statements of operations. The fair value of the Vasconia investment was not material as of September 30, 2025.

Given Vasconia's limited trading activity, recent operating results of Vasconia and impact of the bankruptcy related activity, the fair value of the Vasconia investment was measured using the income approach based on Level 3 unobservable inputs.

Prior to accounting for the investment in Vasconia at fair value, equity in losses, net of taxes recognized for the nine months ended September 30, 2024 was $2.1 million.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

On March 13, 2025, the Company and Vasconia entered into Amendment No. 6 of the Shares Subscription Agreement, which among other items, terminated the Company's rights to designate individuals to be nominated as members of the Vasconia board of directors. The Company did not have any designated members nominated to the Vasconia board of directors as of the date of the amendment.

**NOTE 5 — INTANGIBLE ASSETS**

Intangible assets consisted of the following as of September 30, 2025 and December 31, 2024 (in thousands):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross** | **Impairment** | **Accumulated<br>Amortization** | **Net** | **Gross** | **Accumulated<br>Amortization** | **Net** |
| **Goodwill**<sup>(1)</sup> | $33237 | $(33237) | $— | $— | $33237 | $— | $33237 |
| **Finite-lived intangible assets:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Licenses | 15847 |  | (12908) | 2939 | 15847 | (12566) | 3281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade names | 104614 |  | (33717) | 70897 | 104459 | (28619) | 75840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer relationships | 143159 |  | (80886) | 62273 | 143157 | (73505) | 69652 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 5894 |  | (4732) | 1162 | 5868 | (4351) | 1517 |
| **Total** | $302751 | $(33237) | $(132243) | $137271 | $302568 | $(119041) | $183527 |

---

<sup>(1)</sup> The net value at September 30, 2025 reflects a reduction of $113.0 million impairment charges within U.S. segment and $11.9 million impairment charges within International segment. The gross and net value at December 31, 2024 reflect a reduction of $79.8 million impairment charges within U.S. segment and $11.9 million impairment charges within International segment.

*Goodwill impairment test*

In the second quarter of 2025, the Company observed a sustained decline in the market valuation of the Company's common stock. Additionally, the Company's near term forecasts for the U.S. reporting unit were revised downward due to changes in retailer and consumer buying patterns, which were impacted by the recent changes in the U.S. tariff policies. Based on these factors the Company concluded that impairment indicators for the U.S. reporting unit were present as of June 30, 2025.

The Company performed an interim impairment test of the goodwill in the U.S. reporting unit as of June 30, 2025 by comparing its fair value with its carrying value. The analysis was performed by using a discounted cash flow and market multiple method. Accordingly, this fair value measurement is classified as Level 3 since it is based primarily on unobservable inputs. Based upon the analysis performed, the Company's U.S. reporting unit goodwill was fully impaired and a $33.2 million non-cash goodwill impairment charge was recognized. The goodwill impairment charge was the result of the decline in the Company's near term forecasts that were revised downward due to the changes in retailer and consumer buying patterns and an increase to the company-specific risk premium, which is an input to the cost of capital assumption, to address the potential risks in the long-term forecast which remain uncertain at this time. As of September 30, 2025, the Company's goodwill balance was zero.

**NOTE 6 — DEBT**

On August 26, 2022, the Company entered into Amendment No. 2 (the "Amendment") to the Company's credit agreement, dated as of March 2, 2018 (as amended, the "ABL Agreement") among the Company, as a Borrower, certain subsidiaries of the Company, as Borrowers and/or Loan Parties, JPMorgan Chase Bank, N.A., as Administrative Agent and a Lender. The ABL Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027.

On November 14, 2023, the Company entered into Amendment No. 2 to amend the Loan Agreement, dated as of March 2, 2018, among the Company, as borrower, the other loan parties from time to time party thereto, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, the "Term Loan" and together with the ABL Agreement, the "Debt Agreements"). The Term Loan has a principal amount of $150.0 million, and matures on August 26, 2027.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

The Term Loan requires the Company to make quarterly payments of principal each equal to 1.25% of the aggregate principal amount of the Term Loan, which commenced on March 31, 2024, with the remaining balance payable on the maturity date. The Term Loan requires the Company to make an annual prepayment of principal, beginning with those for the fiscal year ending December 31, 2024, based upon a percentage of the Company's excess cash flow, ("Excess Cash Flow"), if any. The percentage applied to the Company's Excess Cash Flow is based on the Company's Total Net Leverage Ratio (as defined in the Debt Agreements). When an Excess Cash Flow payment is required, each lender has the option to decline a portion or all of the prepayment amount payable to it. Per the Term Loan, when the Company makes an Excess Cash Flow prepayment, the payment is first applied to satisfy the next eight (8) scheduled future quarterly required payments of the Term Loan in order of maturity and then to the remaining scheduled installments on a pro rata basis.

The maximum borrowing amount under the ABL Agreement may be increased to up to $250.0 million if certain conditions are met. One or more tranches of additional term loans (the "Incremental Term Facilities") may be added under the Term Loan if certain conditions are met. The Incremental Facilities may not exceed the sum of (i) $50.0 million plus (ii) an unlimited amount so long as, in the case of (ii) only, the Company's secured net leverage ratio, as defined in and computed on a pro forma basis pursuant to the Term Loan, after giving effect to such increase, is no greater than 3.25 to 1.00, subject to certain limitations and for the period defined pursuant to the Term Loan but not to mature earlier than the maturity date of the then existing term loans.

As of September 30, 2025 and December 31, 2024, the total availability under the ABL Agreement were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Maximum aggregate principal allowed | $200000 | $176329 |
| Outstanding borrowings under the ABL Agreement | (62411) | (42693) |
| Standby letters of credit | (11564) | (8828) |
| Total availability under the ABL Agreement | $126025 | $124808 |

---

Availability under the ABL Agreement is limited to the lesser of the $200.0 million commitment thereunder and the borrowing base and therefore depends on the valuation of certain current assets comprising the borrowing base. The borrowing capacity under the ABL Agreement will depend, in part, on eligible levels of accounts receivable and inventory that fluctuate regularly. Due to the seasonality of the Company's business, the Company may have greater borrowing availability during the third and fourth quarters of each year. Consequently, the $200.0 million commitment thereunder may not represent actual borrowing capacity. The Company's borrowing capacity may be further limited by the Term Loan financial covenant of 5.00 to 1.00 maximum Total Net Leverage Ratio. As of September 30, 2025, the availability under the ABL Agreement, limited by the Term Loan financial covenant, was $25.2 million.

The current and non-current portions of the Company's Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Current portion of Term Loan: |  |  |
| &nbsp;&nbsp;Term Loan payment | $7500 | $7500 |
| &nbsp;&nbsp;Estimated unamortized debt issuance costs | (2513) | (2609) |
| **Total Current portion of Term Loan** | $4987 | $4891 |
| Non-current portion of Term Loan: |  |  |
| &nbsp;&nbsp;Term Loan, net of current portion | $129375 | $135000 |
| &nbsp;&nbsp;Estimated unamortized debt issuance costs | (2179) | (4051) |
| **Total Non-current portion of Term Loan** | $127196 | $130949 |

---

The 2024 excess cash flow payment of $1.2 million was paid on April 4, 2025 and reduced the scheduled quarterly payment due on June 30, 2025. As of September 30, 2025, the Company estimates no excess cash flow payment will be due for 2025.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

The Company's payment obligations under its Debt Agreements are unconditionally guaranteed by its existing and future U.S. subsidiaries with certain minor exceptions. Certain payment obligations under the ABL Agreement are also direct obligations of its foreign subsidiary borrowers designated as such under the ABL Agreement and, subject to limitations on such guaranty, are guaranteed by the foreign subsidiary borrowers, as well as by the Company. The obligations of the foreign subsidiary borrowers under the ABL Agreement are secured by security interests in substantially all of the assets of, and stock in, such foreign subsidiary borrowers, subject to certain limitations. The obligations of the Company under the Debt Agreements and any hedging arrangements and cash management services and the guarantees by its domestic subsidiaries in respect of those obligations are secured by security interests in substantially all of the assets and stock (but in the case of foreign subsidiaries, limited to 65% of the capital stock in first-tier foreign subsidiaries and not including the stock of subsidiaries of such first-tier foreign subsidiaries) owned by the Company and the U.S. subsidiary guarantors, subject to certain exceptions. Such security interests consist of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the "ABL Collateral") pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the "Term Loan Collateral") pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement.

Borrowings under the revolving credit facility bear interest, at the Company's option, at one of the following rates: (i) an alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.5% or one-month Adjusted Term Secured Overnight Financing Rate ("SOFR") plus 1.0% as of a specified date in advance of the determination, but in each case not less than 1.0%, plus a margin of 0.25% to 0.50%, or (ii) Adjusted Term SOFR, which is the Term SOFR Rate for the selected 1, 3 or 6 month interest period plus 0.10% (or Euro Interbank Offered Rate "EURIBOR" for borrowings denominated in Euro; or Sterling Overnight Index Average "SONIA" for borrowings denominated in Pounds Sterling), but in each case not less than zero, plus a margin of 1.25% to 1.50%. The respective margins are based upon average quarterly availability, as defined in and computed pursuant to the ABL Agreement. In addition, the Company pays a commitment fee of 0.20% to 0.25% per annum based on the average daily unused portion of the aggregate commitment under the ABL Agreement. The interest rate on outstanding borrowings under the ABL Agreement at September 30, 2025 was between 3.27% and 5.76%. The Company paid a commitment fee of 0.25% on the unused portion of the ABL Agreement during the nine months ended September 30, 2025.

The Term Loan bears interest, at the Company's option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of (x) the prime rate, (y) a federal funds and overnight bank funding based rate plus 0.5% or (z) one-month Adjusted Term SOFR, but not less than 1.0%, plus 1.0%, plus a margin of 4.5% or (ii) Adjusted Term SOFR (Term SOFR plus the Term SOFR Adjustment) for the applicable interest period, but not less than 1.0%, plus a margin of 5.5%. The interest rate on outstanding borrowings under the Term Loan at September 30, 2025 was 9.75%.

The Debt Agreements provide for customary restrictions and events of default. Restrictions include limitations on additional indebtedness, liens, acquisitions, investments and payment of dividends, among other things. Under the Term Loan, the Total Net Leverage Ratio is not permitted to be greater than 5.00 to 1.00 determined as of the end of each fiscal quarters. Further, the ABL Agreement provides that during any period (a) commencing on the last day of the most recently ended four consecutive fiscal quarters on or prior to the date availability under the ABL Agreement is less than the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement at any time and (b) ending on the day after such availability has exceeded the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement for 45 consecutive days, the Company is required to maintain a minimum fixed charge coverage ratio of 1.10 to 1.00 as of the last day of any period of four consecutive fiscal quarters.

The Company was in compliance with the covenants of the Debt Agreements at September 30, 2025.

The Company expects that it will continue to borrow, subject to availability, and repay funds under the ABL Agreement based on working capital and other corporate needs.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 7** — **DERIVATIVES** 

The Company's risk management strategy includes the use derivative financial instruments to manage its exposure to interest rate movements and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates primarily to offset the earnings impact related to inventory purchases. The Company does not enter into derivative transactions for trading purposes. The Company classifies cash flows from its derivative transactions as cash flows from operating activities in the consolidated statements of cash flows.

The Company's derivatives expose it to credit risks from possible non-performance by counterparties. The Company has limited its credit risk by entering into derivative transactions exclusively with investment-grade rated financial institutions and monitors the creditworthiness of these financial institutions on an ongoing basis. The Company utilizes standard counterparty master netting agreements that net certain foreign currency and interest rate swap transactions in the event of the insolvency of one of the parties to the transaction. These master netting arrangements permit the Company to net amounts due from the Company to counterparty with amounts due to the Company from the same counterparty. Although all of the Company's recognized derivative assets and liabilities are subject to enforceable master netting arrangements, the Company has elected to present these assets and liabilities on a gross basis.

The Company does not anticipate non-performance by any of its counterparties.

*Interest Rate Swap Agreements*

To manage its exposures to interest rate movements, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. These interest rate swaps involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

In March 2024 and October 2024, the Company entered into interest rate swap agreements, each with an aggregate notional value of $25.0 million and expire in August 2027. These non-designated interest rate swaps serve as cash flow hedges of the Company's exposure to the variability of the payment of interest on a portion of its Term Loan borrowings. The Company's total outstanding notional value of interest rate swaps was $50.0 million at September 30, 2025.

*Foreign Exchange Contracts* 

To reduce the impact of changes in foreign currency exchange rates on its results, from time to time the Company is a party to certain foreign exchange contracts, primarily to offset the earnings impact related to fluctuations in foreign currency exchange rates associated with inventory purchases. The Company designates these contracts for accounting purposes as cash flow hedges. The Company purchases foreign currency forward contracts with terms less than 18 months. The aggregate gross notional value of foreign exchange contracts at September 30, 2025 was $3.4 million.

The fair values of the Company's derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| **Derivatives designated as hedging instruments** | **Balance Sheet Location** | **September 30, 2025** | **December 31, 2024** |
| Foreign exchange contracts | Prepaid expenses and other current assets | $— | $256 |
|  | Accrued expenses | 132 |  |

---

---

| | | | |
|:---|:---|:---|:---|
| **Derivatives not designated as hedging instruments** | **Balance Sheet Location** | **September 30, 2025** | **December 31, 2024** |
| Interest rate swaps | Prepaid expenses and other current assets | $— | $102 |
|  | Other assets |  | 379 |
|  | Other long-term liabilities | 428 | 154 |

---

The fair values of the interest rate swaps have been obtained from the counterparties to the agreements and were based on Level 2 observable inputs using proprietary models and estimates about relevant future market conditions. The fair values of the foreign exchange contracts were based on Level 2 observable inputs using quoted market prices for similar assets in an active market.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

The amounts of gains and losses, realized and unrealized, related to the Company's derivative financial instruments designated as hedging instruments are recognized in other comprehensive income, net of taxes, as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| **Derivatives designated as hedging instruments** | **2025** | **2024** | **2025** | **2024** |
| Foreign exchange contracts | $141 | $(203) | $(449) | $20 |

---

Realized gains and losses on foreign exchange contracts that are reported in other comprehensive income are reclassified into cost of sales as the underlying inventory purchased is sold.

During the three and nine months ended September 30, 2025, the Company reclassified $0.03 million and $0.1 million, respectively, of cash flow hedges in accumulated other comprehensive losses to earnings, related to foreign exchange contracts recognized in cost of sales. At September 30, 2025, the estimated amount of existing net losses expected to be reclassified into earnings within the next 12 months was $0.2 million.

During the three and nine months ended September 30, 2024, the Company reclassified $0.03 million and $0.2 million, respectively, of cash flow hedges in accumulated other comprehensive losses to earnings, related to foreign exchange contracts recognized in cost of sales.

Interest and mark to market losses related to the Company's derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|<br>**Derivatives not designated as hedging instruments** |<br>**Location of gain (loss)** | **2025** | **2024** | **2025** | **2024** |
| Interest rate swaps | Mark to market loss on interest rate derivatives | $(8) | $(928) | $(755) | $(1184) |
|  | Interest expense | 65 | 298 | 298 | 828 |
|  |  | $57 | $(630) | $(457) | $(356) |

---

**NOTE 8** — **STOCK COMPENSATION**

As of September 30, 2025, there were 908,049 shares available for the grant of awards under the Company's Amended and Restated 2000 Long Term Incentive Plan ("Plan"), assuming maximum performance of performance-based awards.

*Option Awards*

A summary of the Company's stock option activity and related information for the nine months ended September 30, 2025 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Options** | **Weighted-<br>average<br>exercise price** | **Weighted-<br>average<br>remaining<br>contractual<br>life (years)** | **Aggregate<br>intrinsic<br>value <br>(in thousands)** |
| **Options outstanding, January 1, 2025** | 782500 | $11.41 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants | 44500 | 5.13 |  |  |
| **Options outstanding, September 30, 2025**<sup>(1)</sup> | 827000 | 11.07 | 4.3 | $— |
| **Options exercisable, September 30, 2025** | 700000 | $11.73 | 3.5 | $— |
| **Total unrecognized stock option expense remaining (in thousands)** | $311 |  |  |  |
| **Weighted-average years expected to be recognized over** | 1.6 |  |  |  |

---

<sup>(1)</sup> Includes a non-plan stock option award of 15,000 stock options granted in 2024.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their exercisable in-the-money stock options on September 30, 2025. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company's common stock on September 30, 2025 and the exercise price.

*Restricted Stock*

A summary of the Company's restricted stock activity and related information for the nine months ended September 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Restricted<br>Shares** | **Weighted-<br>average grant<br>date fair<br>value** |
| **Non-vested restricted shares, January 1, 2025** | 593526 | $9.46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants | 588698 | 4.57 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vested | (286320) | 9.96 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forfeitures | (6751) | 7.91 |
| **Non-vested restricted shares, September 30, 2025** | 889153 | $6.07 |
| **Total unrecognized compensation expense remaining (in thousands)** | $4071 |  |
| **Weighted-average years expected to be recognized over** | 1.6 |  |

---

The total fair value of restricted stock that vested during the nine months ended September 30, 2025 was $1.3 million.

*Performance shares*

Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Company's board of directors (the "Board of Directors"). The shares are subject to the terms and conditions of the Company's Plan.

A summary of the Company's performance-based award activity and related information for the nine months ended September 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Performance-**<br>**based stock**<br>**awards** <sup>(1)</sup> | **Weighted-<br>average grant<br>date fair<br>value** |
| **Non-vested performance-based awards, January 1, 2025** | 529407 | $8.96 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants | 331561 | 5.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forfeitures<sup>(2)</sup> | (128796) | 11.96 |
| **Non-vested performance-based awards, September 30, 2025** | 732172 | $6.70 |
| **Total unrecognized compensation expense remaining (in thousands)** | $2110 |  |
| **Weighted-average years expected to be recognized over** | 1.8 |  |

---

<sup>(1)</sup> Represents the target number of shares to be issued for each performance-based award.

<sup>(2)</sup> Includes the forfeiture of performance-based awards granted in 2022 as the performance metric was not attained.

*Cash-settled performance-based awards*

Each cash-settled performance-based award represents the right to receive up to 150% of the target number of deferred stock units with payment in cash equivalent to the value of one share of the Company's common stock. The number of deferred stock units earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board of Directors. The cash-settled performance-based awards are subject to the terms and conditions of the Company's Plan.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

A summary of the Company's cash-settled performance-based awards activity and related information for the nine months ended September 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Cash-settled performance-based awards** <sup>(1)</sup> | **Weighted-<br>average fair<br>value** |
| **Non-vested cash-settled performance-based awards, January 1, 2025** | 82176 | $5.91 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forfeitures<sup>(2)</sup> | (82176) | 5.91 |
| **Non-vested cash-settled performance-based awards, September 30, 2025** |  | $— |
| **Total unrecognized compensation expense remaining (in thousands)** | $— |  |
| **Weighted-average years expected to be recognized over** | 0.0 |  |

---

<sup>(1)</sup> Represents the target number of units to be settled in cash.

<sup>(2)</sup> Includes the forfeiture of performance-based awards granted in 2022 as the performance metric was not attained.

The Company recorded stock compensation expense as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**September 30,** | **Three Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** |
| **Stock Compensation Expense Components** | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity based stock option expense | $50 | $73 | $184 | $183 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted and performance-based stock awards expense | 946 | 973 | 2919 | 2706 |
| **Stock compensation expense for equity based awards** | 996 | 1046 | 3103 | 2889 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liability based stock option expense | (2) | (4) | (3) | (3) |
| **Total Stock Compensation Expense** | $994 | $1042 | $3100 | $2886 |

---

**NOTE 9 —(LOSS) INCOME PER COMMON SHARE**

Basic (loss) income per common share has been computed by dividing net (loss) income by the weighted-average number of shares of the Company's common stock outstanding during the relevant period. Diluted (loss) income per common share adjusts net (loss) income and basic (loss) income per common share for the effect of all potentially dilutive shares of the Company's common stock. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method.

The calculations of basic and diluted (loss) income per common share for the three and nine months ended September 30, 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | (in thousands, except per share amounts) | (in thousands, except per share amounts) | (in thousands, except per share amounts) | (in thousands, except per share amounts) |
| **Net (loss) income – Basic and Diluted** | $(1189) | $344 | $(45089) | $(24083) |
| **Weighted-average shares outstanding – Basic** | 21768 | 21562 | 21683 | 21454 |
| **Effect of dilutive securities:** |  |  |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Stock options and other stock awards |  | 48 |  |  |
| **Weighted-average shares outstanding – Diluted** | 21768 | 21610 | 21683 | 21454 |
| **Basic (loss) income per common share** | $(0.05) | $0.02 | $(2.08) | $(1.12) |
| **Diluted (loss) income per common share** | $(0.05) | $0.02 | $(2.08) | $(1.12) |
| **Antidilutive Securities**<sup>(1)</sup> | 1713 | 1231 | 1571 | 1504 |

---

<sup>(1)</sup> Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 10— INCOME TAXES**

Income tax provision of $2.9 million and income tax benefit of $(0.1) million for the three and nine months ended September 30, 2025, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of 171.1% and benefit rate of 0.14%, respectively. The effective tax rate for the three months ended September 30, 2025 differs from the federal statutory income tax rate of 21.0% primarily due to the impact of non-deductible expenses, foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance and a partial valuation allowance on U.S. deferred tax assets that are not more likely than not to be realized as a result of the goodwill impairment in the second quarter. The effective tax rate for the nine months ended September 30, 2025 differs from the federal statutory income tax rate of 21.0% primarily due to a partial valuation allowance on U.S. deferred tax assets that are not more likely than not to be realized as a result of the goodwill impairment in the second quarter.

Income tax provision of $1.5 million and $1.7 million for the three and nine months ended September 30, 2024, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of 81.4% and (8.2)%, respectively. The effective tax rate for the three months ended September 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The negative rate for the nine months ended September 30, 2024 reflects tax expense on a pretax financial reporting loss. The effective tax rate for the nine months ended September 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to the impact of non-deductible expenses and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance

The Company has identified the following jurisdictions as "major" tax jurisdictions: U.S. Federal, California, Massachusetts, New Jersey, New York and the United Kingdom.

The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. There were no material changes to the Company's uncertain tax positions, interest, or penalties during the three-month periods ended September 30, 2025 and September 30, 2024.

The One Big Beautiful Bill Act ("OBBBA") was enacted on July 4, 2025 with various provisions impacting the Company, including interest expense limitation and deduction of domestic R&D expenses. The Company assessed the impact of OBBBA as not material to the 2025 financial statements.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 11 – BUSINESS SEGMENTS**

**Segment information**

The Company operates in two reportable segments: U.S. and International. The U.S. segment is the Company's domestic business that designs, markets and distributes its products to retailers and distributors, as well as directly to consumers through third parties and its own internet websites primarily in the U.S.. The International segment is the Company's international business that sells and distributes products to consumers primarily in the U.K., the European Union and the Asia Pacific region.

The Company's chief operation decision maker ("CODM") is the Company's Chief Executive Officer. The Company has segmented its operations to reflect the manner in which the CODM reviews and evaluates the results of its operations. The CODM allocates operating and capital resources and evaluates the performance of the Company's segments based on segment net sales, segment gross margin, and segment income (loss) from operations. Such measures give recognition to specifically identifiable operating costs. Significant segment expenses that are included in segment operating income consist of cost of sales, distribution expenses (which include freight-out expenses and warehouse expenses) and selling, general and administrative expenses.

Certain general and administrative expenses are not allocated to the Company's segments as these represent corporate level activities and are reflected below as unallocated corporate expenses. These costs primarily include senior executive salaries and benefits, stock compensation, director fees and accounting, legal fees and consulting fees.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Segment Performance Measures:** | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| **Net sales:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $158121 | $170222 | $405946 | $431205 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 13791 | 13615 | 37913 | 36540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $171912 | $183837 | $443859 | $467745 |
| **Gross Margin:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $55560 | $62721 | $148893 | $166483 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 4864 | 4696 | 13007 | 13031 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total gross margin | $60424 | $67417 | $161900 | $179514 |
| **Income (loss) from operations** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $12941 | $16191 | $(14781) | $34822 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | (2561) | (3292) | (8841) | (9313) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unallocated corporate expenses<sup>(1)</sup> | (3687) | (4286) | (5793) | (13899) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) from operations | $6693 | $8613 | $(29415) | $11610 |

---

<sup>(1)</sup> Unallocated corporate expenses for the nine months ended September 30, 2025 included a net legal settlement gain of $6.4 million. Details see NOTE 12 — CONTINGENCIES

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Supplemental information for significant segment expenses:** | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| **Cost of sales:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $102561 | $107501 | $257053 | $264722 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 8927 | 8919 | 24906 | 23509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | $111488 | $116420 | $281959 | $288231 |
| **Freight-out expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $3624 | $3377 | $10025 | $8733 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 651 | 691 | 1913 | 2151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total freight-out expenses | $4275 | $4068 | $11938 | $10884 |
| **Warehouse expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $10583 | $13205 | $32543 | $32722 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 3081 | 2761 | 8842 | 7661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total warehouse expenses | $13664 | $15966 | $41385 | $40383 |
| **Selling, general and administrative expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $28412 | $29948 | $87869 | $90206 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 3389 | 4536 | 10789 | 12532 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unallocated corporate expenses<sup>(1)</sup> | 3687 | 4286 | 5793 | 13899 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total selling, general and administrative expenses | $35488 | $38770 | $104451 | $116637 |
| **Goodwill impairment:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $— | $— | $33237 | $— |
| **Restructuring expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;International | $304 | $— | $304 | $— |

---

<sup>(1)</sup> Unallocated corporate expenses for the nine months ended September 30, 2025 included a net legal settlement gain of $6.4 million. Details see NOTE 12 — CONTINGENCIES

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| **Depreciation and amortization:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $5063 | $6113 | $15545 | $15381 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 335 | 295 | 988 | 860 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total depreciation and amortization | $5398 | $6408 | $16533 | $16241 |
| **Capital expenditures:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $440 | $450 | $3128 | $1388 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 35 | 56 | 93 | 216 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total capital expenditures | $475 | $506 | $3221 | $1604 |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | (in thousands) | (in thousands) |
| **Assets** |  |  |
| U.S. | $482482 | $542420 |
| International | 84302 | 88961 |
| Unallocated corporate | 14340 | 2929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $581124 | $634310 |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 12** — **CONTINGENCIES**

*Wallace EPA Matter*

Wallace Silversmiths de Puerto Rico, Ltd. ("WSPR"), a wholly-owned subsidiary of the Company, operates a manufacturing facility in San Germán, Puerto Rico that is leased from the Puerto Rico Industrial Development Company ("PRIDCO"). In March 2008, the U.S. Environmental Protection Agency (the "EPA") announced that the San Germán Ground Water Contamination site in Puerto Rico (the "Site") had been added to the Superfund National Priorities List due to organic compounds present in the local drinking water supply.

In May 2008, WSPR received from the EPA a Notice of Potential Liability and Request for Information pursuant to 42 U.S.C. Sections 9607(a) and 9604(e) of the Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA"). In July 2011, WSPR received a letter from the EPA requesting access to the property that it leases from PRIDCO to conduct an environmental investigation, and the Company granted such access. In February 2013, the EPA requested access to conduct a further environmental investigation at the property. PRIDCO agreed to such access and the Company consented. The EPA conducted a further investigation during 2013 and, in April 2015, notified the Company and PRIDCO that the results from vapor intrusion sampling may warrant the implementation of measures to mitigate potential exposure to sub-slab soil gas. The Company reviewed the information provided by the EPA and requested that PRIDCO, as the property owner, find and implement a solution acceptable to the EPA. In order to protect the health of its employees and continue its business operations, WSPR has implemented corrective action measures to respond to vapor intrusion, such as sealing the floors of the building and conducting periodic air monitoring to address potential exposure.

On August 13, 2015, the EPA released its remedial investigation and feasibility study ("RI/FS") for the Site. On December 11, 2015, the EPA issued the Record of Decision ("ROD") for an initial operable unit ("OU-1"), electing to implement its preferred remedy which consists of soil vapor extraction and dual-phase extraction/in-situ treatment. This selected remedy includes soil vapor extraction ("SVE") to address soil (vadose zone) source areas at the Site, impermeable cover as necessary for the implementation of SVE, dual phase extraction in the shallow saprolite zone, and in-situ treatment as needed to address residual sources. The EPA's total net present worth estimated cost for its selected remedy is $7.3 million. In February 2017, the EPA indicated that it planned to expand its field investigation for the RI/FS to a second operable unit ("OU-2") to determine the nature and extent of the groundwater damage at and from the Site and to determine the nature of the remedial action needed to address the damage. The EPA requested access to the property occupied by WSPR to install monitoring wells and to undertake groundwater sampling as part of this expanded investigation. WSPR consented to the EPA's access request, provided that the EPA received PRIDCO's consent as the property owner. The EPA has also issued notices of potential liability to a number of other entities affiliated with the Site, which used the organic compounds of concern.

In December 2018, the Company, WSPR, and other identified potentially responsible parties affiliated with the Site entered into tolling agreements with the U.S. government to extend the statute of limitations for potential claims for the recovery of response costs for the initial operable unit under Section 107 of CERCLA. The tolling agreements have been extended multiple times and currently expire in November 2025. In October 2025, the U.S. government requested that the parties extend the tolling agreement until November 10, 2026. WSPR agreed to the extension. The tolling agreements do not constitute in any way an admission or acknowledgment of any fact, conclusion of law, or liability by the parties to the agreements.

The EPA released its proposed plan for OU-2 in July 2019, and on September 30, 2019, the EPA issued the ROD for OU-2. The EPA elected to implement its preferred remedy consisting of in-situ treatment of groundwater and a monitored natural attenuation program including monitoring of the plume fringe at the Site. The EPA's estimated total net present worth cost for its selected remedy for OU-2 is $17.3 million, and the EPA is currently leading remediation of OU-2.

In August 2021, WSPR received a Notice of Liability for the Site from the Department of Justice on behalf of the EPA, and in September 2021, WSPR responded with a good faith offer to conduct additional testing and remedial design work for OU-1. WSPR actively participated in negotiations among the U.S. Government (the Department of Justice and the EPA) and other potentially responsible parties with respect to the remedial work at OU-1, which negotiations culminated in the finalization of a Consent Decree for Remedial Design and Remedial Action at Operable Unit One of the San German Groundwater Contamination Site ("Decree"). On July 26, 2023, the U.S. Government filed a complaint in United States District Court for the District of Puerto Rico for the purpose of seeking judicial approval of the Decree. As required by applicable regulations, the U.S. Government simultaneously lodged the Decree for public comment. No comments were received during the public

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

comment period. On September 6, 2023, at the conclusion of the public comment period, the U.S. Government filed a Motion to Enter the Decree, and the court entered the Decree into order on December 14, 2023, thereby effectuating the Decree. On January 10, 2024, EPA issued a notice to proceed with the OU-1 remedial work. The Company thereafter commenced remedial work on OU-1 in accordance with the Decree. WSPR submitted the final draft Remedial Design Work Plan, Supplemental Pre-Design Investigation Work Plan, and Pilot Study Work Plan to EPA on May 30, 2025, and awaits EPA approval on those documents to move forward with the remediation.

The Company reserved $5.6 million to cover probable and estimable liabilities with respect to the above remedial design and remedial action for OU-1. However, it is not possible at this time for the Company to estimate its share of its ultimate liability for the Site. In the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company's results of operations could be material. As of September 30, 2025, the remaining probable and reasonably estimable liability related to the above remedial design and remedial action for OU-1 is $5.4 million.

*Legal Settlement Gain*

In 2015, Taylor Precision Products, Inc. ("Taylor" and/or the "Plaintiff"), acquired by the Company on March 2, 2018, commenced a legal action related to a 2013 acquisition, alleging that the seller failed to sufficiently disclose certain adverse information as part of the acquisition. In February 2025, the Company received a net settlement of $6.4 million, which consisted of a $7.0 million settlement less $0.6 million in legal fees related to this case. The Company recognized the gain in selling, general and administrative expenses in the condensed consolidated statement of operations for the quarter ended March 31, 2025.

*Other*

The Company is, from time to time, involved in other legal proceedings. The Company believes that other current litigation is routine in nature and incidental to the conduct of the Company's business and that none of this litigation, individually or collectively, would have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**NOTE 13** — **OTHER**

**Cash dividends**

Dividends declared in the nine months ended September 30, 2025 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Dividend per share** | **Date declared** | **Date of record** | **Payment date** |
| $0.0425 | 3/11/2025 | 5/1/2025 | 5/15/2025 |
| $0.0425 | 6/18/2025 | 8/1/2025 | 8/15/2025 |
| $0.0425 | 8/5/2025 | 10/31/2025 | 11/14/2025 |

---

During the nine months ended September 30, 2025, the Company paid dividends of $2.9 million. This included payments made on February 14, 2025, May 15, 2025 and August 15, 2025 of $0.9 million, $0.9 million and $1.0 million to stockholders of record on January 31, 2025, May 1, 2025 and August 1, 2025 respectively, and payments of $0.1 million for dividends payable upon the vesting of restricted shares.

In the three months ended September 30, 2025, the Company reduced retained earnings for the accrual of $1.0 million relating to the dividend payable on November 14, 2025.

On November 4, 2025, the Board declared a quarterly dividend of $0.0425 per share of common stock payable on February 13, 2026 to stockholders of record on January 30, 2026.

**Stock repurchase program**

On March 14, 2022, the Company announced that its Board of Directors of the Company authorized the repurchase of up to $20.0 million of the Company's common stock, replacing the Company's previously-authorized $10.0 million share repurchase program. The repurchase authorization permits the Company to effect repurchases from time to time through open market purchases and privately negotiated transactions. No shares were repurchased during the nine months ended September 30, 2025. As of September 30, 2025, the remaining dollar amount available for repurchases under the Board of Directors' authorized plan was $11.1 million.

**Supplemental cash flow information**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| | (in thousands) | (in thousands) |
| **Supplemental disclosure of cash flow information:** |  |  |
| Cash paid for interest | $13089 | $14860 |
| Cash paid for taxes, net of refunds | 3012 | 5073 |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIFETIME BRANDS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

(unaudited)

**Components of accumulated other comprehensive loss, net**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| *Accumulated translation adjustment:* |  |  |  |  |
| Balance at beginning of period | $(17772) | $(18369) | $(18384) | $(32614) |
| &nbsp;&nbsp;&nbsp;&nbsp;Translation adjustment during period | (81) | 872 | 531 | 965 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss<sup>(1)</sup> |  |  |  | 14152 |
| Net change in translation adjustment | (81) | 872 | 531 | 15117 |
| Balance at end of period | $(17853) | $(17497) | $(17853) | $(17497) |
| *Accumulated deferred losses on cash flow hedges:* |  |  |  |  |
| Balance at beginning of period | $(343) | $89 | $247 | $(134) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in unrealized gain (losses) | 113 | (235) | (562) | (163) |
| Amounts reclassified from accumulated other comprehensive loss: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Settlement of cash flow hedge <sup>(2)</sup> | 28 | 32 | 113 | 183 |
| Net change in cash flow hedges, net of taxes of $0, $0, $0, $0 | 141 | (203) | (449) | 20 |
| Balance at end of period | $(202) | $(114) | $(202) | $(114) |
| *Accumulated effect of retirement benefit obligations:* |  |  |  |  |
| Balance at beginning of period | $(170) | $(726) | $(178) | $(751) |
| Amounts reclassified from accumulated other comprehensive loss: <sup>(3)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial loss, net of taxes of $(1), $(5), $(4), $(13) | 5 | 13 | 13 | 38 |
| Balance at end of period | $(165) | $(713) | $(165) | $(713) |
| Total accumulated other comprehensive loss at end of period | $(18220) | $(18324) | $(18220) | $(18324) |

---

<sup>(1)</sup> Amounts reclassified to the Vasconia investment carrying value as a result of the discontinuation of the equity method investment of accounting and recognized as a loss on equity securities in the unaudited condensed consolidated statements of operations, to reduce the Vasconia investment to its fair value.

<sup>(2)</sup> Amounts reclassified are recorded in cost of sales on the unaudited condensed consolidated statement of operations.

<sup>(3)</sup> Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

This Quarterly Report on Form 10-Q of Lifetime Brands, Inc. (the "Company" and, unless the context otherwise requires, references to the "Company" shall include its consolidated subsidiaries), contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q are forward-looking statements. These forward-looking statements include information concerning the Company's plans, objectives, goals, strategies, future events, future revenues, performance, capital expenditures, financing needs and other information that is not historical information. Many of these statements appear, in particular, in *Management's Discussion and Analysis of Financial Condition and Results of Operations.* When used in this Quarterly Report on Form 10-Q, the words "estimates," "expects," "intends," "predicts," "plans," "believes," "may," "should," "would," and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, those based on the Company's examination of historical operating trends, are based upon the Company's current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and assumptions, but there can be no assurance that the Company will realize its expectations or that the Company's assumptions will prove correct.

There are a number of risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. Important factors that could cause the Company's actual results to differ materially from those expressed as forward-looking statements include, without limitation, those set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the "2024 Annual Report on Form 10-K") in Part I, Item 1A under the heading *Risk Factors,* and in the Company's subsequent filings with the U.S. Securities and Exchange Commission (the "SEC"). Such risks, uncertainties and other important factors include, among others, risks related to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Macroeconomic conditions, including labor disputes, depreciation of the U.S. dollar, volatility in the capital markets, inflationary impacts and disruptions to the global supply chain;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increase in supply chain costs, including raw materials, sourcing, transportation and energy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of tariffs and trade policies, particularly with respect to China;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Indebtedness, compliance with credit agreements, and access to credit markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Access to the capital markets and credit markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The seasonality of the Company's cash flows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's ability to complete acquisitions or successfully integrate acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Intense market competition, changing customer practices or preferences and inventory rationalization among retailers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Dependence on third-party manufacturers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Technology, cybersecurity and data privacy risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Geopolitical conditions, including political instability in the U.S. and abroad, unrest and sanctions, war, conflict, including the ongoing conflicts between Russia and the Ukraine, conflicts in the Middle East, and increasing tensions between China and Taiwan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legislative and regulatory risk, including those relating to the recent enactment of the OBBBA and the impact of a continued shutdown of the U.S. government;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Product liability claims; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reputational risks.

There may be other factors that may cause the Company's actual results to differ materially from the forward-looking statements. Except as may be required by law, the Company undertakes no obligation to publicly update or revise forward-looking statements which may be made to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

The Company is required to file its Annual Reports on Forms 10-K, Quarterly Reports on Forms 10-Q, Current Reports on Form 8-K, and other reports and documents as required from time to time with the SEC. The Company also maintains a website at *<u>http://www.lifetimebrands.com</u>*. Information contained on this website is not a part of or incorporated by reference into this Quarterly Report on Form 10-Q. The Company makes available on its website the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to these reports as soon as reasonably

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

practicable after these reports are filed with or furnished to the SEC. Users can access these reports free of charge on the Company's website. The SEC also maintains a website that contains reports, proxy and information statements, and other information regarding the Company's electronic filings with the SEC at *<u>http://www.sec.gov.</u>*

The Company intends to use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on the Company's website in the 'Investor Relations' section. Accordingly, investors should monitor such portion of the Company's website, in addition to following the Company's press releases, SEC filings and public conference calls and webcasts.

**ABOUT THE COMPANY**

The Company designs, sources and sells branded kitchenware, tableware and other products used in the home. The Company's product categories include two categories of products used to prepare, serve, and consume foods: Kitchenware (kitchen tools, cutlery, kitchen scales, thermometers, cutting boards, shears, cookware, pantryware, spice racks, and bakeware) and Tableware (dinnerware, stemware, flatware, and giftware); and one category, Home Solutions, which comprises other products used in the home (thermal beverageware, bath scales, weather and outdoor household products, food storage, neoprene travel products and home décor).

The Company markets several product lines within each of its product categories and under most of the Company's brands, primarily targeting moderate price points through virtually every major level of trade. The Company believes it possesses certain competitive advantages based on its brands, its emphasis on innovation and new product development, and its sourcing capabilities. The Company owns or licenses a number of leading brands in its industry, including Farberware<sup>®</sup>, KitchenAid<sup>®</sup> Mikasa<sup>®</sup>, Taylor<sup>®</sup>, Pfaltzgraff<sup>®</sup>, Built NY<sup>®</sup>, S'well<sup>®</sup>, Fred<sup>®</sup> & Friends, KitchenCraft<sup>®</sup> , Rabbit<sup>®</sup>, Kamenstein<sup>®</sup>, and Dolly<sup>®</sup>. Historically, the Company's sales growth has come from expanding product offerings within its product categories, by developing existing brands, acquiring new brands (including complementary brands in markets outside the United States), and establishing new product categories. Key factors in the Company's growth strategy have been the selective use and management of the Company's brands and the Company's ability to provide a stream of new products and designs. A significant element of this strategy is the Company's in-house design and development teams that create new products, packaging and merchandising concepts.

**RECENT DEVELOPMENTS**

The Company sources almost all of its product from third-party manufacturers outside the U.S., primarily in China. This geographic concentration in suppliers exposes the Company to risks associated with doing business globally, including risks relating to changes in U.S. tariff and trade policies. New or increased tariffs, quotas, embargoes, or other trade barriers could adversely impact our supply chain and cost structure. To mitigate the impact of these tariffs, the Company has negotiated price increases to its U.S. customers, negotiated lower product costs with its foreign suppliers and pursues diversification of its foreign sourced products to countries that are expected to be subject to lower tariffs. The Company's tariff mitigation strategy is intended to maintain the Company's gross margin dollars and therefore, may result in a decline in gross margin percentage. If tariffs rates were to increase further and the Company is unable to mitigate the impact of the increase cost, it would result in lower gross margin from the sale of its products. The broader macroeconomic impacts related to the changes in tariff policies including potential mitigation efforts by retailers may negatively impact consumer spending and buying patterns of the Company's products. This could materially adversely affect the Company's results of operations and financial condition.

In January 2025, the Company announced the relocation of the Company's east coast distribution operations currently located in Robbinsville, NJ (the "Robbinsville Facility") to Hagerstown, Maryland (the "Hagerstown Facility"). In connection with the relocation, the Company expects to incur exit costs of approximately $7.0 million for employee severance, certain employee relocation costs, and remaining lease costs for the Robbinsville Facility, which costs are expected to be incurred in 2025 and 2026.

The Hagerstown Facility will require capital expenditures for equipment and certain leasehold improvements of approximately $9.0 million. Start-up costs are estimated to be approximately $7.0 million, which includes recruitment, relocation of inventory, set up costs and lease expenses prior to the Hagerstown Facility being fully operational. These one-time costs are expected to be incurred in 2026. The Company expects that the Hagerstown Facility will be operational in the second quarter of 2026. Additionally, in connection with the relocation to the Hagerstown Facility, the Company will receive tax abatement and incentives over the term of the lease from the State of Maryland and Washington County, Maryland totaling approximately $13.1 million. These incentives include real property tax abatement, employee state withholding tax credit, conditional grants and income tax credits.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

In January 2025, the Company launched Project Concord, management's comprehensive plan to propel growth and streamline the cost structure of its International operations. The Company expects this plan to improve future results of its International segment through sales growth and the identified costs efficiencies. On July 8, 2025, the Company announced a reorganization of its international workforce in connection with Project Concord. The reorganization primarily affected the structure of the International segment's merchandising and sales workforce. The restructuring expenses related to severance associated with the reorganization of $0.3 million was recorded in the third quarter of 2025.

**BUSINESS SEGMENTS**

The Company operates in two reportable segments: U.S. and International. The U.S. segment is the Company's domestic business that designs, markets and distributes its products to retailers and distributors, as well as directly to consumers through third parties and its own internet websites primarily in the U.S.. The International segment is the Company's international business that sells and distributes products to consumers primarily in the U.K., the European Union and the Asia Pacific region.

Additional information regarding the Company's reportable segments is included in NOTE 11 – BUSINESS SEGMENTS of the Notes to the condensed consolidated financial statements included in Item 1.

**SEASONALITY**

The Company's business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2024 and 2023, net sales for the third and fourth quarters accounted for 58% and 57% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period.

Consistent with the seasonality of the Company's net sales and inventory levels, the Company also experiences seasonality in its inventory turnover and turnover days from one quarter to the next.

**CRITICAL ACCOUNTING ESTIMATES**

There have been no material changes to the Company's critical accounting estimates discussed in the 2024 Annual Report on Form 10-K in Item 7 under the heading *Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates*.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**RESULTS OF OPERATIONS**

The following table sets forth statements of operations data of the Company as a percentage of net sales for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | 64.9 | 63.3 | 63.5 | 61.6 |
| Gross margin | 35.1 | 36.7 | 36.5 | 38.4 |
| Distribution expenses | 10.4 | 10.9 | 12.0 | 11.0 |
| Selling, general and administrative expenses | 20.6 | 21.1 | 23.5 | 24.9 |
| Goodwill impairment |  |  | 7.5 |  |
| Restructuring expenses | 0.2 |  | 0.1 |  |
| Income (loss) from operations | 3.9 | 4.7 | (6.6) | 2.5 |
| Interest expense | (2.9) | (3.2) | (3.4) | (3.5) |
| Mark to market loss on interest rate derivatives |  | (0.5) | (0.2) | (0.3) |
| Loss on equity securities |  |  |  | (3.0) |
| Income (loss) before income taxes and equity in losses | 1.0 | 1.0 | (10.2) | (4.3) |
| Income tax (provision) benefit | (1.7) | (0.8) |  | (0.4) |
| Equity in losses, net of taxes |  |  |  | (0.4) |
| Net (loss) income | (0.7)% | 0.2% | (10.2)% | (5.1)% |

---

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**MANAGEMENT'S DISCUSSION AND ANALYSIS**

**THREE MONTHS ENDED SEPTEMBER 30, 2025 COMPARED TO THE THREE MONTHS ENDED**

**SEPTEMBER 30, 2024** 

**Net Sales**

Consolidated net sales for the three months ended September 30, 2025 were $171.9 million, representing a decrease of $11.9 million, or 6.5%, as compared to net sales of $183.8 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations and was determined by applying 2025 average rates to 2024 local currency amounts, consolidated net sales decreased by $12.5 million, or 6.8%, as compared to consolidated net sales in the corresponding period in 2024.

Net sales for the U.S. segment for the three months ended September 30, 2025 were $158.1 million, a decrease of $12.1 million, or 7.1%, as compared to net sales of $170.2 million for the corresponding period in 2024. For the three months ended September 30, 2025, net sales were favorably impacted by higher selling prices, reflecting the implementation of price increases for the Company's U.S. customers that became effective during the third quarter of 2025. This impact was offset by lower sales volume, as price increases softened consumer demand and certain retailers shifted the timing of orders.

Net sales for the U.S. segment's Kitchenware product category were $98.6 million for the three months ended September 30, 2025, an increase of $1.3 million, or 1.3%, as compared to $97.3 million for the corresponding period in 2024. The increase was driven by higher sales for cutlery and boards and kitchen measurement products. These increases were offset by a reduction in sales for bakeware and barware products.

Net sales for the U.S. segment's Tableware product category were $31.6 million for the three months ended September 30, 2025, a decrease of $9.3 million, or 22.7%, as compared to $40.9 million for the corresponding period in 2024. The decrease was attributable to lower warehouse club programs for dinnerware and flatware.

Net sales for the U.S. segment's Home Solutions product category were $27.9 million for the three months ended September 30, 2025, a decrease of $4.1 million, or 12.8%, as compared to $32.0 million for the corresponding period in 2024. The decrease was attributable to lower sales for home décor and bath measurement products, which was partially offset by higher sales in the back-to-school lunch box category.

Net sales for the International segment were $13.8 million for the three months ended September 30, 2025, an increase of $0.2 million, or 1.5%, as compared to net sales of $13.6 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations, net sales decreased by $0.4 million, or 2.7%, as compared to consolidated net sales in the corresponding period in 2024. The decrease in constant currency net sales was driven by lower sales in the U.K., partially offset by higher sales in the Asia Pacific region.

**Gross margin**

Gross margin for the three months ended September 30, 2025 was $60.4 million, or 35.1%, as compared to $67.4 million, or 36.7%, for the corresponding period in 2024.

Gross margin for the U.S. segment was $55.5 million, or 35.1%, for the three months ended September 30, 2025, as compared to $62.7 million, or 36.8%, for the corresponding period in 2024. The decrease in the gross margin percentage was attributable to higher selling prices, offset by higher tariffs. The decrease in gross margin dollars was driven by lower sales volume.

Gross margin for the International segment was $4.9 million, or 35.5%, for the three months ended September 30, 2025, as compared to $4.7 million, or 34.6%, for the corresponding period in 2024. The increase in gross margin percentage was driven by customer and product mix.

**Distribution expenses**

Distribution expenses for the three months ended September 30, 2025 were $17.9 million, as compared to $20.0 million for the corresponding period in 2024. Distribution expenses as a percentage of net sales were 10.4% for the three months ended September 30, 2025, as compared to 10.9% for the three months ended September 30, 2024.

Distribution expenses as a percentage of net sales for the U.S. segment were 9.0% and 9.7% for the three months ended September 30, 2025 and 2024, respectively. Distribution expense during the three months ended September 30, 2025 and 2024 included $0.1 million and $0.6 million, respectively, for redesign costs related to the Company's warehouses. As a percentage

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

of sales shipped from the Company's U.S. warehouses, excluding non-recurring expenses, distribution expenses were 8.5% and 10.1% for the three months ended September 30, 2025 and 2024, respectively. The decrease in expenses as a percentage of sales was attributable to lower depreciation expense due to changes in asset retirement obligation estimates in the prior year, improved labor management efficiencies resulting in a decrease of employee expenses and higher sales volume due to sales mix resulting in a favorable impact of fixed expenses. The decrease was partially offset by higher software expenses due to the launch of a new warehouse management system at the Company's west coast distribution center in September 2024.

Distribution expenses as a percentage of net sales for the International segment were 27.1% for the three months ended September 30, 2025, compared to 25.4% for the corresponding period in 2024. As a percentage of sales shipped from the Company's international warehouses distribution expenses were 22.6% and 24.2% for the three months ended September 30, 2025 and 2024, respectively. The decrease in expenses as a percentage of sales was due to lower freight-out expenses and higher shipment volume due to sales mix resulting in favorable impact of fixed expenses, partially offset by an increase in expense due to expanded distribution of the Company's products within the Asia Pacific region.

**Selling, general and administrative expenses**

Selling, general and administrative expenses for the three months ended September 30, 2025 were $35.5 million, a decrease of $3.3 million, or 8.5%, as compared to $38.8 million for the corresponding period in 2024.

Selling, general and administrative expenses for the U.S. segment were $28.4 million for the three months ended September 30, 2025, as compared to $29.9 million for the corresponding period in 2024. As a percentage of net sales, selling, general and administrative expenses were 18.0% and 17.6% for the three months ended September 30, 2025 and 2024, respectively. The decrease in selling, general and administrative expenses was attributable to lower employee expenses, including incentive compensation, partially offset by an increase in amortization expense related to an indefinite-lived trade name, which was reclassified to a finite-lived trade name in the fourth quarter 2024. The increase in selling, general and administrative expenses as a percentage of net sales, was attributable to the impact of fixed costs on lower sales volume.

Selling, general and administrative expenses for the International segment were $3.4 million for the three months ended September 30, 2025, as compared to $4.5 million for the corresponding period in 2024. As a percentage of net sales, selling, general and administrative expenses were 24.6% and 33.1% for the three months ended September 30, 2025 and 2024, respectively. The decrease in expenses was due to lower employee expenses, lower advertising and commission expenses, and the prior year expense included penalties related to tax filings.

Unallocated corporate expense for the three months ended September 30, 2025 was $3.7 million, as compared to $4.3 million for the corresponding period in 2024. The decrease compared to the prior period was due to lower incentive compensation and legal expenses.

**Restructuring expense**

Restructuring expenses for the International segment were $0.3 million for the three months ended September 30, 2025, which was related to severance associated with the reorganization of the International segment's workforce. The reorganization is in connection with Project Concord and primarily affects the structure of the International segment's merchandising and sales workforce.

**Interest expense**

Interest expense was $5.0 million and $5.8 million for the three months ended September 30, 2025 and 2024, respectively. The decrease in expense was a result of lower average outstanding borrowings in the current period, and lower interest rates on outstanding borrowings.

**Mark to market loss on interest rate derivatives**

Mark to market loss on interest rate derivatives was $0.01 million for the three months ended September 30, 2025, as compared to $0.9 million for the three months ended September 30, 2024. The loss recognized for the three months ended September 30, 2025 and 2024, respectively, was attributable to the change in the fair value due to the change in the projected interest rate environment. The mark to market amount represents the change in fair value on the Company's interest rate derivatives that have not been designated as hedging instruments. These derivatives were entered into for purposes of locking-in a fixed interest rate on a portion of the Company's variable interest rate debt. As of September 30, 2025, the intent of the Company is to hold these derivative contracts until their maturity.

**Income taxes**

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

Income tax provision of $2.9 million and $1.5 million for the three months ended September 30, 2025 and 2024, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of 171.1% and 81.4%, respectively. The effective tax rate for the three months ended September 30, 2025 differs from the federal statutory income tax rate of 21.0% primarily due to the impact of non-deductible expenses, foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance and a partial valuation allowance on U.S. deferred tax assets that are not more likely than not to be realized as a result of the goodwill impairment in the second quarter. The effective tax rate for the three months ended September 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance.

**MANAGEMENT'S DISCUSSION AND ANALYSIS**

**NINE MONTHS ENDED SEPTEMBER 30, 2025 COMPARED TO THE NINE MONTHS ENDED**

**SEPTEMBER 30, 2024** 

**Net Sales**

Consolidated net sales for the nine months ended September 30, 2025 were $443.9 million, a decrease of $23.8 million, or 5.1%, as compared to net sales of $467.7 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations and was determined by applying 2025 average rates to 2024 local currency amounts, consolidated net sales decreased by $24.9 million, or 5.3%, as compared to consolidated net sales in the corresponding period in 2024.

Net sales for the U.S. segment for the nine months ended September 30, 2025 were $406.0 million, a decrease of $25.2 million, or 5.8%, as compared to net sales of $431.2 million for the corresponding period in 2024. For the nine months ended September 30, 2025, net sales were favorably impacted by higher selling prices, reflecting the implementation of price increases for the Company's U.S. customers that became effective during the third quarter of 2025. This impact was offset by lower sales volume, as price increases softened consumer demand and certain retailers shifted the timing of orders.

Net sales for the U.S. segment's Kitchenware product category were $260.7 million for the nine months ended September 30, 2025, a decrease of $1.0 million, or 0.4%, as compared to $261.7 million for the corresponding period in 2024. The decrease was driven by lower sales for kitchen tools, bakeware and barware, partially offset by higher sales for cutlery and boards and kitchen measurement products.

Net sales for the U.S. segment's Tableware product category were $80.5 million for the nine months ended September 30, 2025, a decrease of $12.5 million, or 13.4%, as compared to $93.0 million for the corresponding period in 2024. The decrease was driven by lower flatware sales due to a warehouse club program not repeated, partially offset by higher sales in dinnerware in the dollar channel.

Net sales for the U.S. segment's Home Solutions product category were $64.8 million for the nine months ended September 30, 2025, a decrease of $11.7 million, or 15.3%, as compared to $76.5 million for the corresponding period in 2024. The decrease was attributable to lower sales of hydration products and bath measurement products. The decrease was partially offset by higher sales in the back-to-school lunch box category.

Net sales for the International segment were $37.9 million for the nine months ended September 30, 2025, an increase of $1.4 million, or 3.8%, as compared to net sales of $36.5 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations, net sales increased by $0.3 million, or 0.9%, as compared to consolidated net sales in the corresponding period in 2024. The increase was attributable to higher sales in the Asia Pacific region, partially offset by lower sales in the U.K.

**Gross margin**

Gross margin for the nine months ended September 30, 2025 was $161.9 million, or 36.5%, as compared to $179.5 million, or 38.4%, for the corresponding period in 2024.

Gross margin for the U.S. segment was $148.9 million, or 36.7%, for the nine months ended September 30, 2025, as compared to $166.5 million, or 38.6%, for the corresponding period in 2024. The decrease in the gross margin percentage was attributable to higher selling prices, offset by higher tariffs. The decrease in gross margin dollars was driven by lower sales volume.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

Gross margin for the International segment was $13.0 million, or 34.3%, for the nine months ended September 30, 2025, as compared to $13.0 million, or 35.6%, for the corresponding period in 2024. The decrease in gross margin percentage was driven by customer and product mix.

**Distribution expenses**

Distribution expenses for the nine months ended September 30, 2025 were $53.3 million, as compared to $51.3 million for the corresponding period in 2024. Distribution expenses as a percentage of net sales were 12.0% for the nine months ended September 30, 2025, as compared to 11.0% for the nine months ended September 30, 2024.

Distribution expenses as a percentage of net sales for the U.S. segment were 10.5% and 9.6% for the nine months ended September 30, 2025 and 2024, respectively. Distribution expenses during the nine months ended September 30, 2025 and 2024 included $0.2 million and $0.7 million, respectively, for redesign costs related to the Company's warehouses. As a percentage of sales shipped from the Company's U.S. warehouses, excluding non-recurring expenses, distribution expenses were 10.3% and 10.0% for the nine months ended September 30, 2025 and 2024, respectively. The increase in expenses as a percentage of sales was attributable to an increase in freight-out expenses, higher software expenses due to the launch of a new warehouse management system at the Company's west coast distribution center in September 2024, partially offset by lower depreciation expense due to changes in asset retirement obligation estimates in the prior year.

Distribution expenses as a percentage of net sales for the International segment were 28.4% for the nine months ended September 30, 2025, compared to 26.9% for the corresponding period in 2024. As a percentage of sales shipped from the Company's international warehouses, distribution expenses were 24.6% and 24.3% for the nine months ended September 30, 2025 and 2024, respectively. The increase in expenses as a percentage of sales was primarily attributed to higher warehouse expenses related to the expanded distribution of the Company's products within the Asia Pacific region, partially offset by a decrease in freight-out expenses.

**Selling, general and administrative expenses**

Selling, general and administrative expenses for the nine months ended September 30, 2025 were $104.5 million, a decrease of $12.1 million, or 10.4%, as compared to $116.6 million for the corresponding period in 2024.

Selling, general and administrative expenses for the U.S. segment were $87.9 million for the nine months ended September 30, 2025, as compared to $90.2 million for the corresponding period in 2024. As a percentage of net sales, selling, general and administrative expenses were 21.7% and 20.9% for the nine months ended September 30, 2025 and 2024, respectively. The decrease in selling, general and administrative expenses was attributable to lower employee expenses, including incentive compensation, partially offset by an increase in provision for doubtful accounts in the current period, and an increase in amortization expense related to an indefinite-lived trade name, which was reclassified to a finite-lived trade name in the fourth quarter 2024. The increase in selling, general and administrative expenses as a percentage of net sales, was attributable to the impact of fixed costs on lower sales volume.

Selling, general and administrative expenses for the International segment were $10.8 million for the nine months ended September 30, 2025, as compared to $12.5 million for the corresponding period in 2024. As a percentage of net sales, selling, general and administrative expenses were 28.5% and 34.2% for the nine months ended September 30, 2025 and 2024, respectively. The decrease was primarily attributable to foreign currency exchange gains, lower advertising expenses and commissions, and the prior year expense included penalties related to tax filings.

Unallocated corporate expenses for the nine months ended September 30, 2025 were $5.8 million, as compared to expenses of $13.9 million for the corresponding period in 2024. The decrease in expenses was driven by the recognition of a net legal settlement gain of $6.4 million in the current period, lower incentive compensation, legal expenses and professional fees, partially offset by an increase in stock compensation expense.

**Goodwill impairment**

During the second quarter of 2025, the Company's qualitative assessment of goodwill indicated triggering events had occurred in its U.S. reporting unit. The Company performed an interim impairment test of the goodwill in the U.S. reporting unit as of June 30, 2025, that resulted in a $33.2 million non-cash goodwill impairment charge.

**Restructuring expense**

Restructuring expenses for the International segment were $0.3 million for the nine months ended September 30, 2025, which was related to severance associated with the reorganization of the International segment's workforce. The reorganization is in

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

connection with Project Concord and primarily affects the structure of the International segment's merchandising and sales workforce.

**Interest expense**

Interest expense was $15.0 million and $16.6 million for the nine months ended September 30, 2025 and 2024, respectively. The decrease in expense was a result of lower average outstanding borrowings in the current period, and lower interest rates on outstanding borrowings.

**Mark to market loss on interest rate derivatives**

Mark to market loss on interest rate derivatives was $0.8 million for the nine months ended September 30, 2025, as compared to $1.2 million for the nine months ended September 30, 2024. The decrease was attributable to the change in the fair value based on the increase in interest rates. The mark to market amount represents the change in fair value on the Company's interest rate derivatives that have not been designated as hedging instruments. These derivatives were entered into for purposes of locking-in a fixed interest rate on a portion of the Company's variable interest rate debt. As of September 30, 2025, the intent of the Company is to hold these derivative contracts until their maturity.

**Loss on equity securities**

Loss on equity securities was $14.2 million for the nine months ended September 30, 2024. In the second quarter of 2024, the Company lost significant influence over its investment in Vasconia and discontinued the equity method of accounting. This change resulted in the reclassification of previously recognized accumulated other comprehensive losses to the investment balance and subsequently resulted in a non-cash loss of $14.2 million, to reduce the investment to its fair value. NOTE 4 —INVESTMENT for additional information.

**Income taxes**

Income tax benefit of $(0.1) million and income tax provision of $1.7 million for the nine months ended September 30, 2025 and 2024, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax benefit rate of 0.14% and provision rate of (8.2)%, respectively. The effective tax rate for the nine months ended September 30, 2025 differs from the federal statutory income tax rate of 21.0% primarily due to a partial valuation allowance on U.S. deferred tax assets that are not more likely than not to be realized as a result of the goodwill impairment in the second quarter. The negative rate for the nine months ended September 30, 2024 reflects tax expense on a pretax financial reporting loss. The effective tax rate for the nine months ended September 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to the impact of non-deductible expenses and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance.

**Equity in losses, net of taxes**

Equity in losses of Vasconia, net of taxes**,** was $2.1 million for the nine months ended September 30, 2024.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**LIQUIDITY AND CAPITAL RESOURCES**

The Company's principal sources of cash to fund liquidity needs are: (i) cash provided by operating activities and (ii) borrowings available under its revolving credit facility under the ABL Agreement, as defined below. The Company's primary uses of funds consist of working capital requirements, capital expenditures, acquisitions and investments, payments of dividends, and payments of principal and interest on its debt.

At September 30, 2025, the Company had cash and cash equivalents of $12.1 million, compared to $2.9 million at December 31, 2024. Working capital was $236.4 million at September 30, 2025, compared to $221.8 million at December 31, 2024. Liquidity as of September 30, 2025 was $50.9 million, consisting of $12.1 million of cash and cash equivalents, $25.2 million of availability under the ABL Agreement, limited by the Term Loan financial covenant, and $13.6 million of available funding under the Receivables Purchase Agreement.

Inventory, a large component of the Company's working capital, is expected to fluctuate from period to period, with inventory levels higher primarily in the June through October time period. The Company also expects inventory turnover to fluctuate from period to period based on product and customer mix. Certain product categories have lower inventory turnover rates as a result of minimum order quantities from the Company's vendors or customer replenishment needs. Certain other product categories experience higher inventory turns due to lower minimum order quantities or trending sale demands. For the three months ended September 30, 2025, inventory turnover was 2.0 times, or 181 days, as compared to 2.1 times, or 175 days, for the three months ended September 30, 2024. Inventory turns have remained relatively consistent.

The Company believes that availability under the revolving credit facility under its ABL Agreement, cash on hand and cash flows from operations are sufficient to fund the Company's operations for the next twelve months. However, if circumstances were to adversely change, the Company may seek alternative sources of liquidity including debt and/or equity financing. However, there can be no assurance that any such alternative sources would be available or sufficient.

The Company closely monitors the creditworthiness of its customers. Based upon its evaluation of changes in customers' creditworthiness, the Company may modify credit limits and/or terms of sale. However, notwithstanding the Company's efforts to monitor its customers' financial condition, the Company could be materially adversely affected by future changes in these conditions.

**Indebtedness**

On August 26, 2022, the Company entered into Amendment No. 2 (the "Amendment") to the Company's credit agreement, dated as of March 2, 2018 (as amended, the "ABL Agreement") among the Company, as a Borrower, certain subsidiaries of the Company, as Borrowers and/or Loan Parties, JPMorgan Chase Bank, N.A., as Administrative Agent and a Lender. The ABL Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027.

On November 14, 2023, the Company entered into Amendment No. 2 to amend the Loan Agreement, dated as of March 2, 2018, among the Company, as borrower, the other loan parties from time to time party thereto, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, the "Term Loan" and together with the ABL Agreement, the "Debt Agreements"). The Term Loan has a principal amount of $150.0 million, and matures on August 26, 2027.

The Term Loan requires the Company to make quarterly payments of principal each equal to 1.25% of the aggregate principal amount of the Term Loan, which commenced on March 31, 2024, with the remaining balance payable on the maturity date. The Term Loan requires the Company to make an annual prepayment of principal, beginning with those for the fiscal year ending December 31, 2024, based upon a percentage of the Company's excess cash flow, ("Excess Cash Flow"), if any. The percentage applied to the Company's Excess Cash Flow is based on the Company's Total Net Leverage Ratio (as defined in the Debt Agreements). When an Excess Cash Flow payment is required, each lender has the option to decline a portion or all of the prepayment amount payable to it. Per the Term Loan, when the Company makes an Excess Cash Flow prepayment, the payment is first applied to satisfy the next eight (8) scheduled future quarterly required payments of the Term Loan in order of maturity and then to the remaining scheduled installments on a pro rata basis.

The maximum borrowing amount under the ABL Agreement may be increased to up to $250.0 million if certain conditions are met. One or more tranches of additional term loans (the "Incremental Term Facilities") may be added under the Term Loan if certain conditions are met. The Incremental Facilities may not exceed the sum of (i) $50.0 million plus (ii) an unlimited amount so long as, in the case of (ii) only, the Company's secured net leverage ratio, as defined in and computed on a pro forma basis

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

pursuant to the Term Loan, after giving effect to such increase, is no greater than 3.25 to 1.00, subject to certain limitations and for the period defined pursuant to the Term Loan but not to mature earlier than the maturity date of the then existing term loans.

As of September 30, 2025 and December 31, 2024, the total availability under the ABL Agreement were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Maximum aggregate principal allowed | $200000 | $176329 |
| Outstanding borrowings under the ABL Agreement | (62411) | (42693) |
| Standby letters of credit | (11564) | (8828) |
| Total availability under the ABL Agreement | $126025 | $124808 |

---

Availability under the ABL Agreement is limited to the lesser of the $200.0 million commitment thereunder and the borrowing base and therefore depends on the valuation of certain current assets comprising the borrowing base. The borrowing capacity under the ABL Agreement will depend, in part, on eligible levels of accounts receivable and inventory that fluctuate regularly. Due to the seasonality of the Company's business, the Company may have greater borrowing availability during the third and fourth quarters of each year. Consequently, the $200.0 million commitment thereunder may not represent actual borrowing capacity. The Company's borrowing capacity may be further limited by the Term Loan financial covenant of 5.00 to 1.00 maximum Total Net Leverage Ratio. As of September 30, 2025, the availability under the ABL Agreement, limited by the Term Loan financial covenant, was $25.2 million.

The current and non-current portions of the Company's Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Current portion of Term Loan: |  |  |
| &nbsp;&nbsp;Term Loan payment | $7500 | $7500 |
| &nbsp;&nbsp;Estimated unamortized debt issuance costs | (2513) | (2609) |
| **Total Current portion of Term Loan** | $4987 | $4891 |
| Non-current portion of Term Loan: |  |  |
| &nbsp;&nbsp;Term Loan, net of current portion | $129375 | $135000 |
| &nbsp;&nbsp;Estimated unamortized debt issuance costs | (2179) | (4051) |
| **Total Non-current portion of Term Loan** | $127196 | $130949 |

---

The 2024 excess cash flow payment of $1.2 million was paid on April 4, 2025 and reduced the scheduled quarterly payment due on June 30, 2025. As of September 30, 2025, the Company estimates no excess cash flow payment will be due for 2025.

The Company's payment obligations under its Debt Agreements are unconditionally guaranteed by its existing and future U.S. subsidiaries with certain minor exceptions. Certain payment obligations under the ABL Agreement are also direct obligations of its foreign subsidiary borrowers designated as such under the ABL Agreement and, subject to limitations on such guaranty, are guaranteed by the foreign subsidiary borrowers, as well as by the Company. The obligations of the foreign subsidiary borrowers under the ABL Agreement are secured by security interests in substantially all of the assets of, and stock in, such foreign subsidiary borrowers, subject to certain limitations. The obligations of the Company under the Debt Agreements and any hedging arrangements and cash management services and the guarantees by its domestic subsidiaries in respect of those obligations are secured by security interests in substantially all of the assets and stock (but in the case of foreign subsidiaries, limited to 65% of the capital stock in first-tier foreign subsidiaries and not including the stock of subsidiaries of such first-tier foreign subsidiaries) owned by the Company and the U.S. subsidiary guarantors, subject to certain exceptions. Such security interests consist of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the "ABL Collateral") pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the "Term Loan Collateral") pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

Borrowings under the revolving credit facility bear interest, at the Company's option, at one of the following rates: (i) an alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.5% or one-month Adjusted Term Secured Overnight Financing Rate ("SOFR") plus 1.0% as of a specified date in advance of the determination, but in each case not less than 1.0%, plus a margin of 0.25% to 0.50%, or (ii) Adjusted Term SOFR, which is the Term SOFR Rate for the selected 1, 3 or 6 month interest period plus 0.10% (or Euro Interbank Offered Rate "EURIBOR" for borrowings denominated in Euro; or Sterling Overnight Index Average "SONIA" for borrowings denominated in Pounds Sterling), but in each case not less than zero, plus a margin of 1.25% to 1.50%. The respective margins are based upon average quarterly availability, as defined in and computed pursuant to the ABL Agreement. In addition, the Company pays a commitment fee of 0.20% to 0.25% per annum based on the average daily unused portion of the aggregate commitment under the ABL Agreement. The interest rate on outstanding borrowings under the ABL Agreement at September 30, 2025 was between 3.27% and 5.76%. The Company paid a commitment fee of 0.25% on the unused portion of the ABL Agreement during the nine months ended September 30, 2025.

The Term Loan bears interest, at the Company's option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of (x) the prime rate, (y) a federal funds and overnight bank funding based rate plus 0.5% or (z) one-month Adjusted Term SOFR, but not less than 1.0%, plus 1.0%, plus a margin of 4.5% or (ii) Adjusted Term SOFR (Term SOFR plus the Term SOFR Adjustment) for the applicable interest period, but not less than 1.0%, plus a margin of 5.5%. The interest rate on outstanding borrowings under the Term Loan at September 30, 2025 was 9.75%.

The Debt Agreements provide for customary restrictions and events of default. Restrictions include limitations on additional indebtedness, liens, acquisitions, investments and payment of dividends, among other things. Under the Term Loan, the Total Net Leverage Ratio is not permitted to be greater than 5.00 to 1.00 determined as of the end of each fiscal quarters. Further, the ABL Agreement provides that during any period (a) commencing on the last day of the most recently ended four consecutive fiscal quarters on or prior to the date availability under the ABL Agreement is less than the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement at any time and (b) ending on the day after such availability has exceeded the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement for 45 consecutive days, the Company is required to maintain a minimum fixed charge coverage ratio of 1.10 to 1.00 as of the last day of any period of four consecutive fiscal quarters.

The Company was in compliance with the covenants of the Debt Agreements at September 30, 2025.

The Company expects that it will continue to borrow, subject to availability, and repay funds under the ABL Agreement based on working capital and other corporate needs.

*Covenant Calculations*

Adjusted EBITDA (a non-GAAP financial measure), which is defined in the Company's Debt Agreements, is used in the calculation of the Fixed Charge Coverage Ratio, Secured Net Leverage Ratio, Total Leverage Ratio and Total Net Leverage Ratio, which are required to be provided to the Company's lenders pursuant to its Debt Agreements.

The Company's adjusted EBITDA (including pro forma adjustments), for the trailing twelve months ended September 30, 2025 was $47.2 million.

Capital expenditures for the nine months ended September 30, 2025 were $3.2 million.

*Non-GAAP financial measure*

Adjusted EBITDA is a non-GAAP financial measure within the meaning of Regulation G and Item 10(e) of Regulation S-K, each promulgated by the SEC. This measure is provided because management of the Company uses this financial measure in evaluating the Company's on-going financial results and trends, and management believes that exclusion of certain items allows for more accurate period-to-period comparison of the Company's operating performance by investors and analysts. Management also uses this non-GAAP information as an indicator of business performance. Adjusted EBITDA, as discussed above, is also one of the measures used to calculate financial covenants required to be provided to the Company's lenders pursuant to its Debt Agreements.

Investors should consider this non-GAAP financial measure in addition to, and not as a substitute for, the Company's financial performance measures prepared in accordance with U.S. GAAP. Further, the Company's non-GAAP information may be different from the non-GAAP information provided by other companies including other companies within the home retail industry.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

The following is a reconciliation of the net income (loss), as reported, to Adjusted EBITDA, for each of the last four quarters and the 12 months ended September 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter Ended** | **Quarter Ended** | **Quarter Ended** | **Quarter Ended** | **Twelve Months Ended September 30, 2025** |
| | **December 31, 2024** | **March 31,<br>2025** | **June 30,<br>2025** | **September 30,<br>2025** | **Twelve Months Ended September 30, 2025** |
| | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| Net income (loss) as reported | $8918 | $(4201) | $(39699) | $(1189) | $(36171) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax provision (benefit) | 1671 | (142) | (2782) | 2861 | 1608 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 5603 | 4915 | 5054 | 5013 | 20585 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6073 | 5698 | 5437 | 5398 | 22606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on disposition of fixed assets |  |  |  | (94) | (94) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark to market (gain) loss on interest rate derivatives | (718) | 527 | 220 | 8 | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment |  |  | 33237 |  | 33237 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 1034 | 1062 | 1044 | 994 | 4134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal settlement gain, net<sup>(1)</sup> |  | (4578) |  |  | (4578) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance expense |  |  | 270 |  | 270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related expenses | 143 |  | 123 | 49 | 315 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring expenses |  |  |  | 304 | 304 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warehouse redesign expenses<sup>(2)</sup> | 249 |  | 139 | 76 | 464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro forma adjustments<sup>(3)</sup> |  |  |  |  | 4500 |
| Adjusted EBITDA<sup>(4)</sup> | $22973 | $3281 | $3043 | $13420 | $47217 |

---

<sup>(1)</sup> For the twelve months ended September 30, 2025, legal settlement gain, net included a net settlement of $6.4 million discussed in NOTE 12 — CONTINGENCIES, and adjusted for legal fees incurred from March 2, 2018 through March 31, 2025 of $1.8 million.

<sup>(2)</sup> For the twelve months ended September 30, 2025, the warehouse redesign expenses were related to the U.S. segment.

<sup>(3)</sup> Pro forma adjustments represent the amount of operating expense reductions projected by the Company as a result of actions taken through September 30, 2025 or expected to be taken within 18 months of September 30, 2025, net of the benefits realized during the twelve months ended September 30, 2025. These actions include cost savings initiatives for the U.S. segment related to reductions in employee expenses (i.e., including terminated employees, furloughed employees and temporary salary reductions) and costs saving for the International segment related to Project Concord.

<sup>(4)</sup> Adjusted EBITDA is a non-GAAP financial measure that is defined in the Company's debt agreements. Adjusted EBITDA is defined as net income (loss), adjusted to exclude income tax provision (benefit), interest expense, depreciation and amortization, gain on disposition of fixed assets, mark to market (gain) loss on interest rate derivatives, goodwill impairment, stock compensation expense, legal settlement gain, net and other items detailed in the table above that are consistent with exclusions permitted by our debt agreements.

*Accounts Receivable Purchase Agreement*

To improve its liquidity during seasonally high working capital periods, the Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association ("HSBC") as Purchaser (the "Receivables Purchase Agreement"). Under the Receivables Purchase Agreement, the Company may offer to sell certain eligible accounts receivable (the "Receivables") to HSBC, which may accept such offer, and purchase the offered Receivables. Under the Receivables Purchase Agreement, following each purchase of Receivables, the outstanding aggregate purchased Receivables shall not exceed $30.0 million. HSBC will assume the credit risk of the Receivables purchased, and the Company will continue to be responsible for all non-credit risk matters. The Company will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of HSBC. The term of the agreement is for 364 days and shall automatically be extended for annual successive terms unless terminated. Either party may terminate the agreement at any time upon sixty days' prior written notice to the other party.

The Company did not sell receivables to HSBC during the three and nine months ended September 30, 2025 and September 30, 2024. At September 30, 2025, $13.6 million of accounts receivables were available for sale to HSBC, net of applicable charges.

**Derivatives**

The Company's risk management strategy includes the use derivative financial instruments to manage its exposure to interest rate movements and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates primarily to offset the earnings impact related to inventory purchases. The Company does not enter into derivative

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

transactions for trading purposes. The Company classifies cash flows from its derivative transactions as cash flows from operating activities in the consolidated statements of cash flows.

The Company's derivatives expose it to credit risks from possible non-performance by counterparties. The Company has limited its credit risk by entering into derivative transactions exclusively with investment-grade rated financial institutions and monitors the creditworthiness of these financial institutions on an ongoing basis. The Company utilizes standard counterparty master netting agreements that net certain foreign currency and interest rate swap transactions in the event of the insolvency of one of the parties to the transaction. These master netting arrangements permit the Company to net amounts due from the Company to counterparty with amounts due to the Company from the same counterparty. Although all of the Company's recognized derivative assets and liabilities are subject to enforceable master netting arrangements, the Company has elected to present these assets and liabilities on a gross basis.

The Company does not anticipate non-performance by any of its counterparties.

*Interest Rate Swaps*

To manage its exposures to interest rate movements, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. These interest rate swaps involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

In March 2024 and October 2024, the Company entered into interest rate swap agreements, each with an aggregate notional value of $25.0 million and expire in August 2027. These non-designated interest rate swaps serve as cash flow hedges of the Company's exposure to the variability of the payment of interest on a portion of its Term Loan borrowings. The Company's total outstanding notional value of interest rate swaps was $50.0 million at September 30, 2025.

*Foreign Exchange Contracts*

To reduce the impact of changes in foreign currency exchange rates on its results, from time to time the Company is a party to certain foreign exchange contracts, primarily to offset the earnings impact related to fluctuations in foreign currency exchange rates associated with inventory purchases. The Company designates these contracts for accounting purposes as cash flow hedges. The Company purchases foreign currency forward contracts with terms less than 18 months. The aggregate gross notional value of foreign exchange contracts at September 30, 2025 was $3.4 million.

**Operating activities**

Net cash provided by operating activities was $3.9 million for the nine months ended September 30, 2025, as compared to net cash used in operating activities of $1.7 million for the nine months ended September 30, 2024. The increase from 2025 compared to 2024 was attributable to a net legal settlement gain received in the current period, lower investment in inventory, and timing of collections related to the Company's accounts receivables, partially offset by timing of payments for accounts payable and accrued expenses.

**Investing activities**

Net cash used in investing activities was $3.1 million and $1.6 million for the nine months ended September 30, 2025 and 2024, respectively. The increase in investment activities was driven by purchases of equipment for the Hagerstown Facility.

**Financing activities**

Net cash provided by financing activities was $8.3 million for the nine months ended September 30, 2025, as compared to net cash used in financing activities of $6.9 million for the nine months ended September 30, 2024. The change was attributable to higher net proceeds from revolving credit facility in the 2025 period, compare to net repayments of revolving credit facility in the 2025 period.

**Stock repurchase program**

On March 14, 2022, the Company announced that its Board of Directors of the Company authorized the repurchase of up to $20.0 million of the Company's common stock, replacing the Company's previously-authorized $10.0 million share repurchase program. The repurchase authorization permits the Company to effect repurchases from time to time through open market purchases and privately negotiated transactions. No shares were repurchased during the nine months ended September 30, 2025. As of September 30, 2025, the remaining dollar amount available for repurchases under the Board of Directors' authorized plan was $11.1 million.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

There were no material changes in market risk for changes in foreign currency exchange rates and interest rates from the information provided in Item 7A – Quantitative and Qualitative Disclosures About Market Risk in the 2024 Annual Report on Form 10-K.

**Item 4. Controls and Procedures**

**(a)Evaluation of Disclosure Controls and Procedures**

The Chief Executive Officer and the Chief Financial Officer of the Company (its principal executive officer and principal financial officer, respectively) have concluded, based on their evaluation as of September 30, 2025, that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed by it under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer of the Company, as appropriate to allow timely decisions regarding required disclosure.

**(b)Changes in Internal Controls**

There were no changes in the Company's internal controls over financial reporting that occurred during the Company's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings**

For a description of the Company's legal proceedings, please see NOTE 12 — CONTINGENCIES, to the Company's condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

**Item 1A. Risk Factors**

In addition to the other information set forth in this Quarterly Report on Form 10-Q, readers should carefully consider the factors discussed in Part I, Item 1A—Risk Factors in the 2024 Annual Report on Form 10-K, and in the Company's other filings with the SEC, which could materially affect the Company's business, financial condition, cash flows or future results. Except as noted below, there have been no material changes from the risk factors previously disclosed in Part I, Item 1A—Risk Factors in the 2024 Annual Report on Form 10-K**.**

***We face risks related to the uncertainty regarding the future of international trade agreements and the United States' position on international trade. Significant political, trade, regulatory developments, and other circumstances beyond our control, are expected to have a material impact on our business, financial condition, and results of operations if we are unable to successfully implement various mitigating actions.***

The Company sources almost all of its products from suppliers located outside the United States, primarily in China. Additionally, the Company has a presence in international markets through subsidiaries and affiliate companies that are based outside of the United States, including in China. As a result of the tariffs announced on April 2, 2025 by the Trump Administration, we are anticipating increased supply chain challenges, cost volatility, and consumer and economic uncertainty due to rapid changes in global trade policies. We continue to analyze the impact of these tariffs on our business and actions we can take to minimize their impact. We expect these new tariffs to have a material impact on our business and results of operations in fiscal year 2025 and in the longer term if we are unable to successfully implement various mitigating actions noted below.

Uncertainty regarding policies of the Trump Administration with respect to the future of trade partnerships and relations, including as a result of the tariffs announced on April 2, 2025 and additional tariffs that may be announced or implemented in the future, are expected to impact our market share, revenue and gross margins and reduce our competitiveness in countries that will be affected by those policies. In addition, these developments may also negatively impact the carrying value of our reporting units.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

As a result of the tariffs announced on April 2, 2025 or additional tariffs or other restrictions, quotas, embargoes, or safeguards that are placed on goods imported into the United States, or any related counter-measures that are taken by other countries, we expect to take actions which may include, but not be limited to, pricing of our products, product configurations, and inventory management. The actions that we take may not fully offset the impact of tariffs and, as a result, our market share, revenue, gross margins, and results of operations may be materially harmed.

**Item 5. Other Information**

*Rule 10b5-1 Trading Plans*

None of the Company's directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company's fiscal quarter ended September 30, 2025.

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**Item 6. Exhibits**

See the Exhibit Index below, which is incorporated by reference herein.

**Exhibit Index**

---

| | |
|:---|:---|
| **Exhibit No.** | |
| 31.1\* | <u>[Certification by Robert B. Kay, Chief Executive Officer and Director, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31109302025.htm)</u> |
| 31.2\* | <u>[Certification by Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex-31209302025.htm)</u> |
| 32.1\*\* | <u>[Certification by Robert B. Kay, Chief Executive Officer and Director, and Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32109302025.htm)</u> |
| 101.INS\* | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB\* | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101 |

---

\*&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith

\*\*&nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith

------

**<u>[**Table of Contents**](#i77ef68f3fc204c9ba7520d18e4264663_7)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| Lifetime Brands, Inc. |  |
| /s/ Robert B. Kay | November 6, 2025 |
| Robert B. Kay |  |
| Chief Executive Officer and Director |  |
| (Principal Executive Officer) |  |
| /s/ Laurence Winoker | November 6, 2025 |
| Laurence Winoker |  |
| Executive Vice President, Treasurer and Chief Financial Officer |  |
| (Principal Financial and Accounting Officer) |  |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, Robert B. Kay, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lifetime Brands, Inc. ("the registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)4) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected or is reasonably likely to materially affect the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Robert B. Kay |
| Robert B. Kay<br>Chief Executive Officer and Director |
| Date: November 6, 2025 |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, Laurence Winoker, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Lifetime Brands, Inc. ("the registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)4) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected or is reasonably likely to materially affect the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ Laurence Winoker |
| Laurence Winoker<br>Executive Vice President,<br>Treasurer and Chief Financial Officer |
| Date: November 6, 2025 |

---

## Exhibit 32.1

**Exhibit 32.1**

Certification by Robert B. Kay, Chief Executive Officer and Director, and Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

I, Robert B. Kay, Chief Executive Officer and Director, and I, Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, of Lifetime Brands, Inc., a Delaware corporation (the "Company"), each hereby certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Company's periodic report on Form 10-Q for the period ended September 30, 2025 (the "Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| /s/ Robert B. Kay | /s/ Laurence Winoker |
| Robert B. Kay<br>Chief Executive Officer and Director | Laurence Winoker<br>Executive Vice President, Treasurer and Chief Financial Officer |
| Date: November 6, 2025 | Date: November 6, 2025 |

---

A signed original of this certification required by 18 U.S.C. Section 1350 has been provided to Lifetime Brands, Inc. and will be retained by Lifetime Brands, Inc. and furnished to the SEC or its staff upon request.

<br>